<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T02:58:13Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:7959346" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:7959346</identifier>
        <datestamp>2021-03-25</datestamp>
        <setSpec>plosone</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">PLoS One</journal-id>
              <journal-id journal-id-type="iso-abbrev">PLoS One</journal-id>
              <journal-id journal-id-type="publisher-id">plos</journal-id>
              <journal-id journal-id-type="pmc">plosone</journal-id>
              <journal-title-group>
                <journal-title>PLoS ONE</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1932-6203</issn>
              <publisher>
                <publisher-name>Public Library of Science</publisher-name>
                <publisher-loc>San Francisco, CA USA</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC7959346</article-id>
              <article-id pub-id-type="pmcid">PMC7959346</article-id>
              <article-id pub-id-type="pmc-uid">7959346</article-id>
              <article-id pub-id-type="pmid">33720941</article-id>
              <article-id pub-id-type="doi">10.1371/journal.pone.0248726</article-id>
              <article-id pub-id-type="publisher-id">PONE-D-20-34880</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Research Article</subject>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Medical Conditions</subject>
                    <subj-group>
                      <subject>Cardiovascular Diseases</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Cardiology</subject>
                    <subj-group>
                      <subject>Cardiovascular Medicine</subject>
                      <subj-group>
                        <subject>Cardiovascular Diseases</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Genetics</subject>
                    <subj-group>
                      <subject>Single Nucleotide Polymorphisms</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Vascular Medicine</subject>
                    <subj-group>
                      <subject>Blood Pressure</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Biochemistry</subject>
                    <subj-group>
                      <subject>Hormones</subject>
                      <subj-group>
                        <subject>Peptide Hormones</subject>
                        <subj-group>
                          <subject>Natriuretic Peptide</subject>
                          <subj-group>
                            <subject>Brain Natriuretic Peptide</subject>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Medical Conditions</subject>
                    <subj-group>
                      <subject>Cardiovascular Diseases</subject>
                      <subj-group>
                        <subject>Cardiovascular Disease Risk</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Cardiology</subject>
                    <subj-group>
                      <subject>Cardiovascular Medicine</subject>
                      <subj-group>
                        <subject>Cardiovascular Diseases</subject>
                        <subj-group>
                          <subject>Cardiovascular Disease Risk</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Vascular Medicine</subject>
                    <subj-group>
                      <subject>Blood Pressure</subject>
                      <subj-group>
                        <subject>Hypertension</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Genetics</subject>
                    <subj-group>
                      <subject>Heredity</subject>
                      <subj-group>
                        <subject>Genetic Mapping</subject>
                        <subj-group>
                          <subject>Variant Genotypes</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Genetics</subject>
                    <subj-group>
                      <subject>Genetics of Disease</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Genetic association analysis of the cardiovascular biomarker: N-terminal fragment of pro-B-type natriuretic peptide (NT-proBNP)</article-title>
                <alt-title alt-title-type="running-head">Genetic association of BNP and CVD</alt-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Yang</surname>
                    <given-names>Yuan</given-names>
                  </name>
                  <role content-type="https://casrai.org/credit/">Conceptualization</role>
                  <role content-type="https://casrai.org/credit/">Formal analysis</role>
                  <role content-type="https://casrai.org/credit/">Writing – original draft</role>
                  <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff001">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Zmuda</surname>
                    <given-names>Joseph M.</given-names>
                  </name>
                  <role content-type="https://casrai.org/credit/">Funding acquisition</role>
                  <role content-type="https://casrai.org/credit/">Methodology</role>
                  <role content-type="https://casrai.org/credit/">Project administration</role>
                  <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="aff002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Wojczynski</surname>
                    <given-names>Mary K.</given-names>
                  </name>
                  <role content-type="https://casrai.org/credit/">Data curation</role>
                  <role content-type="https://casrai.org/credit/">Methodology</role>
                  <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff003">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Thyagarajan</surname>
                    <given-names>Bharat</given-names>
                  </name>
                  <role content-type="https://casrai.org/credit/">Data curation</role>
                  <role content-type="https://casrai.org/credit/">Funding acquisition</role>
                  <role content-type="https://casrai.org/credit/">Methodology</role>
                  <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff004">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Christensen</surname>
                    <given-names>Kaare</given-names>
                  </name>
                  <role content-type="https://casrai.org/credit/">Funding acquisition</role>
                  <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff005">
                    <sup>5</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Cvejkus</surname>
                    <given-names>Ryan K.</given-names>
                  </name>
                  <role content-type="https://casrai.org/credit/">Data curation</role>
                  <role content-type="https://casrai.org/credit/">Formal analysis</role>
                  <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff001">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1415-1742</contrib-id>
                  <name>
                    <surname>Kuipers</surname>
                    <given-names>Allison L.</given-names>
                  </name>
                  <role content-type="https://casrai.org/credit/">Conceptualization</role>
                  <role content-type="https://casrai.org/credit/">Data curation</role>
                  <role content-type="https://casrai.org/credit/">Formal analysis</role>
                  <role content-type="https://casrai.org/credit/">Methodology</role>
                  <role content-type="https://casrai.org/credit/">Supervision</role>
                  <role content-type="https://casrai.org/credit/">Writing – original draft</role>
                  <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="corresp" rid="cor001">*</xref>
                </contrib>
              </contrib-group>
              <aff id="aff001">
                <label>1</label>
                <addr-line>Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA, United States of America</addr-line>
              </aff>
              <aff id="aff002">
                <label>2</label>
                <addr-line>Department of Human Genetics, University of Pittsburgh, Pittsburgh, PA, United States of America</addr-line>
              </aff>
              <aff id="aff003">
                <label>3</label>
                <addr-line>Department of Genetics, Washington University in St Louis, St. Louis, MO, United States of America</addr-line>
              </aff>
              <aff id="aff004">
                <label>4</label>
                <addr-line>Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, United States of America</addr-line>
              </aff>
              <aff id="aff005">
                <label>5</label>
                <addr-line>Department of Epidemiology, Biostatistics and Biodemography, Danish Aging Research Center, University of Southern Denmark, Odense C, Denmark</addr-line>
              </aff>
              <contrib-group>
                <contrib contrib-type="editor">
                  <name>
                    <surname>Xiong</surname>
                    <given-names>Momiao</given-names>
                  </name>
                  <role>Editor</role>
                  <xref ref-type="aff" rid="edit1"/>
                </contrib>
              </contrib-group>
              <aff id="edit1">
                <addr-line>University of Texas School of Public Health, UNITED STATES</addr-line>
              </aff>
              <author-notes>
                <fn fn-type="COI-statement" id="coi001">
                  <p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p>
                </fn>
                <corresp id="cor001">* E-mail: <email>kuipers@pitt.edu</email></corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>15</day>
                <month>3</month>
                <year>2021</year>
              </pub-date>
              <pub-date pub-type="collection">
                <year>2021</year>
              </pub-date>
              <volume>16</volume>
              <issue>3</issue>
              <elocation-id>e0248726</elocation-id>
              <history>
                <date date-type="received">
                  <day>5</day>
                  <month>11</month>
                  <year>2020</year>
                </date>
                <date date-type="accepted">
                  <day>3</day>
                  <month>3</month>
                  <year>2021</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© 2021 Yang et al</copyright-statement>
                <copyright-year>2021</copyright-year>
                <copyright-holder>Yang et al</copyright-holder>
                <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
                  <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:href="pone.0248726.pdf"/>
              <abstract>
                <sec id="sec001">
                  <title>Background</title>
                  <p>NT-proBNP is a biomarker of cardiovascular disease (CVD). Little is known about the heritability and genetic variants associated with NT-proBNP. Therefore, we estimated the heritability of and examined genetic associations of SNPs in the BNP gene region with circulating NT-proBNP and prevalent CVD in 4,331 participants from the Long Life Family Study (LLFS).</p>
                </sec>
                <sec id="sec002">
                  <title>Methods and results</title>
                  <p>Genotypes of 10 SNPs from the <italic>NPPB</italic> and <italic>NPPA</italic> regions that encode BNP and A-type natriuretic peptide, respectively, were tested for association with NT-proBNP and prevalent cardiovascular disease and risk factors. We performed analyses using the Sequential Oligogenic Linkage Analysis (SOLAR) program to account for family relatedness, and adjusted all models for age, sex, and field center. The mean age of the LLFS was 69.8 years (range 24–110) with 55.4% females. NT-proBNP was significantly heritable (h<sup>2</sup> = 0.21; P = 4x10<sup>-14</sup>), and the minor alleles of rs632793 (p&lt;0.001) and rs41300100 (p = 0.05) were independently associated with higher serum NT-proBNP levels. Additionally, the minor allele of rs632793 was significantly and consistently associated with lower prevalent CVD, including blood pressures, independent of NT-proBNP level (all P&lt;0.05). Results for prevalent CVD, but not NT-proBNP levels, showed significant interaction by familial generation.</p>
                </sec>
                <sec id="sec003">
                  <title>Conclusion</title>
                  <p>In this family-based study of subjects with exceptional longevity, we identified several allelic variants in the BNP gene region associated with NT-pro-BNP levels and prevalent CVD.</p>
                </sec>
              </abstract>
              <funding-group>
                <award-group id="award001">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000049</institution-id>
                      <institution>National Institute on Aging</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>U19AG063893</award-id>
                </award-group>
                <award-group id="award002">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000049</institution-id>
                      <institution>National Institute on Aging</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>U01AG023712</award-id>
                </award-group>
                <award-group id="award003">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000049</institution-id>
                      <institution>National Institute on Aging</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>U01AG023744</award-id>
                </award-group>
                <award-group id="award004">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000049</institution-id>
                      <institution>National Institute on Aging</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>U01AG023746</award-id>
                </award-group>
                <award-group id="award005">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000049</institution-id>
                      <institution>National Institute on Aging</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>U01AG023749</award-id>
                </award-group>
                <award-group id="award006">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000049</institution-id>
                      <institution>National Institute on Aging</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>U01AG023755</award-id>
                </award-group>
                <award-group id="award007">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000050</institution-id>
                      <institution>National Heart, Lung, and Blood Institute</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>K01HL125658</award-id>
                  <principal-award-recipient>
                    <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1415-1742</contrib-id>
                    <name>
                      <surname>Kuipers</surname>
                      <given-names>Allison</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <funding-statement>The LLFS was supported by the National Institute on Aging (U19AG063893, U01AG023712, U01AG023744, U01AG023746, U01AG023749, and U01AG023755). Dr. Kuipers was supported by grant K01HL125658 (PI: Kuipers) from the National Heart, Lung and Blood Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
              </funding-group>
              <counts>
                <fig-count count="1"/>
                <table-count count="6"/>
                <page-count count="14"/>
              </counts>
              <custom-meta-group>
                <custom-meta id="data-availability">
                  <meta-name>Data Availability</meta-name>
                  <meta-value>The Institutional Review Boards at Boston University, Columbia University, and the University of Pittsburgh, and the Research Ethics Committee at the University of Southern Denmark have stated that only summary statistics can be shared with journals or the public without their review. Most of the data used for this analysis is available on the dbGAP database (accession phs000397.v2.p2), including the genetic, covariate, and outcome data. However, the ntBNP data is not available at dbGAP and must be requested from the LLFS data management coordinating center. Any interested parties may request BNP data by contacting Mike Province (<email>mprovince@wustl.edu</email>), Mary Wojczynski (<email>mwojczynski@wustl.edu</email>), and LeAnne Kniepkamp (<email>l.kniepkamp@wustl.edu</email>).</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
            <notes>
              <title>Data Availability</title>
              <p>The Institutional Review Boards at Boston University, Columbia University, and the University of Pittsburgh, and the Research Ethics Committee at the University of Southern Denmark have stated that only summary statistics can be shared with journals or the public without their review. Most of the data used for this analysis is available on the dbGAP database (accession phs000397.v2.p2), including the genetic, covariate, and outcome data. However, the ntBNP data is not available at dbGAP and must be requested from the LLFS data management coordinating center. Any interested parties may request BNP data by contacting Mike Province (<email>mprovince@wustl.edu</email>), Mary Wojczynski (<email>mwojczynski@wustl.edu</email>), and LeAnne Kniepkamp (<email>l.kniepkamp@wustl.edu</email>).</p>
            </notes>
          </front>
          <body>
            <sec sec-type="intro" id="sec004">
              <title>Introduction</title>
              <p>Cardiovascular disease (CVD) is the leading cause of death globally [<xref rid="pone.0248726.ref001" ref-type="bibr">1</xref>]. B-type natriuretic peptide (BNP) has been established as a diagnostic biomarker for heart failure (HF), a subset of CVD [<xref rid="pone.0248726.ref002" ref-type="bibr">2</xref>]. BNP has also been associated with established risk factors for CVD including hypertension [<xref rid="pone.0248726.ref003" ref-type="bibr">3</xref>], obesity [<xref rid="pone.0248726.ref004" ref-type="bibr">4</xref>] and diabetes [<xref rid="pone.0248726.ref005" ref-type="bibr">5</xref>]. The natriuretic peptide family consists of three peptides: atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), and C-type natriuretic peptide. BNP is released as a pro-hormone (proBNP), and proBNP comprises 108 amino acids, which can be cleaved into two parts: N-terminal fragment proBNP (AA residues 1–76; NT-proBNP), and C-terminal BNP (AA residues77-108) [<xref rid="pone.0248726.ref006" ref-type="bibr">6</xref>]. NT-proBNP persists in the circulation longer, has a higher concentration in plasma, and is more stable in vitro compared to the full length or C-terminal BNP, which makes NT-proBNP a better clinical biomarker [<xref rid="pone.0248726.ref007" ref-type="bibr">7</xref>].</p>
              <p>Cardiomyocyte stretch during abnormal intracardiac pressure is the primary stimulus for BNP expression [<xref rid="pone.0248726.ref008" ref-type="bibr">8</xref>]. As such, circulating BNP serves as a compensatory mechanism to offset the excessive vascular vasoconstriction when there is a decreased pumping capacity of the heart. NT-proBNP levels are used clinically to predict the risk of CVD, diagnose heart failure (HF), and to monitor the prognosis of other CVDs [<xref rid="pone.0248726.ref003" ref-type="bibr">3</xref>, <xref rid="pone.0248726.ref009" ref-type="bibr">9</xref>, <xref rid="pone.0248726.ref010" ref-type="bibr">10</xref>]. A diagnosis of HF can be ruled out if with age-specific low NT-proBNP levels in the non-acute setting, as established by the 2016 European Society of Cardiology guidelines [<xref rid="pone.0248726.ref009" ref-type="bibr">9</xref>]. Specifically, the normal range of NT-proBNP is &lt;125pg/ml in individuals aged &lt;75 years, and &lt;450pg/ml in individuals aged ≥75years [<xref rid="pone.0248726.ref011" ref-type="bibr">11</xref>].</p>
              <p>However, little is known about the genetic determinants of BNP with only a handful of studies evaluating its genetic regulation [<xref rid="pone.0248726.ref012" ref-type="bibr">12</xref>] and only a single study reporting its genetic heritability [<xref rid="pone.0248726.ref013" ref-type="bibr">13</xref>]. The study of heritability included 1,914 Framingham Heart Study participants from which they estimated the heritability of NT-proBNP to be 0.35 after adjustment for age, sex, and clinical variables [<xref rid="pone.0248726.ref013" ref-type="bibr">13</xref>]. Several single nucleotide polymorphisms (SNPs) in the <italic>NPPB</italic> gene region have been associated with NT-proBNP levels and CVD outcomes in population studies [<xref rid="pone.0248726.ref014" ref-type="bibr">14</xref>, <xref rid="pone.0248726.ref015" ref-type="bibr">15</xref>] and clinical studies of patients with coronary artery disease [<xref rid="pone.0248726.ref016" ref-type="bibr">16</xref>].</p>
              <p>In the current study, we aimed to replicate and extend results from a previous study conducted in the Atherosclerotic Risk in Communities (ARIC) cohort [<xref rid="pone.0248726.ref015" ref-type="bibr">15</xref>], of the association of prevalent CVD conditions with common genetic variation in the BNP gene region. Like previous studies, we focused on common, independent genetic variation in the <italic>NPPA</italic>/<italic>NPPB</italic> region, two genes that lie in close proximity to each other and encode for ANP and BNP, respectively. In addition, we expanded on previous findings from ARIC by conducting analyses in generally healthy adults from a unique set of families recruited for exceptional longevity, the Long Life Family Study (LLFS). Compared to ARIC, LLFS is older (69.8 ± 15.5 vs. 54.3 ± 6) with a wider age range (24–110 vs. 45–64), and has a lower prevalence of hypertension. Therefore, not only is the LLFS a sample of individuals at low risk for their age of severe CVDs like HF, but the wide age range also allows for determination of how results may differ by age–a known strong correlate of NT-proBNP levels [<xref rid="pone.0248726.ref017" ref-type="bibr">17</xref>].</p>
            </sec>
            <sec sec-type="materials|methods" id="sec005">
              <title>Methods</title>
              <sec id="sec006">
                <title>Population</title>
                <p>The Long Life Family Study (LLFS) is a family-based multi-center cohort study that enrolled 4,953 predominantly European-ancestry participants between 2006 and 2009 from 539 families with exceptional longevity [<xref rid="pone.0248726.ref018" ref-type="bibr">18</xref>]. Participants were recruited at four study centers: Boston, MA (Boston University), New York, NY (Columbia University), Pittsburgh, PA (University of Pittsburgh), and Denmark (University of Southern Denmark). Potential probands in the US who were at least 79 years old on January 1, 2005, and who had no end-stage renal disease or residence in hospice programs, were pre-screened for eligibility by telephone [<xref rid="pone.0248726.ref018" ref-type="bibr">18</xref>]. In Denmark, individuals who would be aged 90 and above during the study recruitment period were identified through the Danish National Register of Persons, which contains current information on names, addresses, place of birth, marriages, and vital status, and linked to archived parish registers to identify sibships. Eligibility at all centers was assessed by calculating a Family Longevity Selection Score (FLoSS), which was built from the birth date, gender, nation-specific cohort survival probabilities and the number of older living siblings [<xref rid="pone.0248726.ref019" ref-type="bibr">19</xref>]. A FloSS score of 7 or higher was required for a family to be eligible as long as they also met the following criteria: the proband and at least one living sibling and one of their living offspring were willing to participate in the LLFS interview and provide a blood sample [<xref rid="pone.0248726.ref018" ref-type="bibr">18</xref>].</p>
                <p>All baseline LLFS interviews and examinations were conducted in person with portable equipment. All research assistants conducting the exams were centrally trained and certified, and used standard protocols. Copies of all LLFS forms are provided with this manuscript as Supporting Information. The current analysis was done on a subset of 4,331 LLFS participants after excluding 622 participants who were missing serum NT-proBNP measures or measures under the assay detection limit of 5pg/ml (N = 335) or was an outlier (BNP = 27950, N = 1), had current and/or a history of heart failure (N = 218), and those with missing pedigree data (N = 68). Written informed consent was obtained from each LLFS participant, and all study forms and protocols were approved by the Institutional Review Boards at Boston University, Columbia University, and the University of Pittsburgh, and by the Research Ethics Committee at the University of Southern Denmark.</p>
              </sec>
              <sec id="sec007">
                <title>Measurement of NT-proBNP</title>
                <p>Blood samples were collected after a ≥6-hour fast and were shipped on ice within 48 hours to the LLFS central blood laboratory at the University of Minnesota for storage at -80°C until assays were completed. Serum NT-proBNP was measured at baseline in the central laboratory by a Roche e411 Analyzer, which applies the sandwich immunoassay method to quantify NT-proBNP (Roche Diagnostics, Indianapolis, IN). The NT-proBNP inter-assay coefficient of variation (CV) was 2.7% at a mean concentration of 139.9 pg/mL and 5.1% at a mean concentration of 4,707.3 pg/mL.</p>
              </sec>
              <sec id="sec008">
                <title>Genotyping</title>
                <p>Genomic DNA was extracted from peripheral blood samples at the LLFS central blood laboratory at the University of Minnesota and shipped to the LLFS central genomics laboratory at the University of Washington St. Louis for genotyping. All genotype data from the LLFS were obtained from the Human Omni 2.5 v1 (Illumina, CA) genotyping chip, which was used on genomic DNA extracted from peripheral blood samples. In order to replicate previous studies and have enough power to detect associations with multiple comparisons, we focused on SNPs located within the genomic region spanning from the 5’ end of <italic>NPPA</italic> through the 3’ end of <italic>NPPB</italic>, which encode for ANP and BNP, respectively, and lie next to each other on chromosome 1. Both <italic>NPPB</italic> and <italic>NPPA</italic> regions were considered since there is evidence that these two genes share common regulatory sequences [<xref rid="pone.0248726.ref020" ref-type="bibr">20</xref>]. In total, 20 SNPs were directly genotyped in this region on the OMNI Chip. We excluded SNPs whose total number of heterozygotes + minor homozygotes was &lt;10 (N = 5) and selected 1 SNP at random for each set of SNPs with linkage disequilibrium (LD)&gt;0.8 (N = 5 excluded; <xref ref-type="fig" rid="pone.0248726.g001">Fig 1</xref>). After these exclusions, 10 SNPSs were selected for analysis. We coded the remaining SNPs as 0, 1, 2 based on the number of minor alleles. If the number of minor homozygous genotypes was &lt;10, then we combined the minor homozygote genotype with the heterozygote genotype in order to increase power (N = 4; <xref rid="pone.0248726.t001" ref-type="table">Table 1</xref>).</p>
                <fig id="pone.0248726.g001" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0248726.g001</object-id>
                  <label>Fig 1</label>
                  <caption>
                    <title>Linkage disequilibrium in the <italic>NPPB/NPPA</italic> gene region in the LLFS.</title>
                    <p>Pairwise linkage disequilibrium (LD) in the LLFS was calculated and plotted using the gaston package in R for all genotyped SNPs in the BNP gene regions. R<sup>2</sup> values are shown and depicted using a heatmap function. Independent SNPs selected for this analysis are underlined.</p>
                  </caption>
                  <graphic xlink:href="pone.0248726.g001"/>
                </fig>
                <table-wrap id="pone.0248726.t001" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0248726.t001</object-id>
                  <label>Table 1</label>
                  <caption>
                    <title>Description of genotyped SNPs in the <italic>NPPA/NPPB</italic> gene region.</title>
                  </caption>
                  <alternatives>
                    <graphic id="pone.0248726.t001g" xlink:href="pone.0248726.t001"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">SNP</th>
                          <th align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">Chromosome 1 location (bp)<xref ref-type="table-fn" rid="t001fn001">*</xref></th>
                          <th align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">Major/minor allele</th>
                          <th align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">Major homozygote n (%)</th>
                          <th align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">Heterozygote n (%)</th>
                          <th align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">Minor homozygote n (%)</th>
                          <th align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">Minor allele frequency</th>
                          <th align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">Model </th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">
                            <bold>rs198358</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">11844019</td>
                          <td align="left" rowspan="1" colspan="1">A/G</td>
                          <td align="left" rowspan="1" colspan="1">2545 (59.4)</td>
                          <td align="left" rowspan="1" colspan="1">1500 (35.0)</td>
                          <td align="left" rowspan="1" colspan="1">243 (5.7)</td>
                          <td align="left" rowspan="1" colspan="1">0.23</td>
                          <td align="left" rowspan="1" colspan="1">Additive</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">
                            <bold>rs5068</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">11845917</td>
                          <td align="left" rowspan="1" colspan="1">T/C</td>
                          <td align="left" rowspan="1" colspan="1">3843 (89.4)</td>
                          <td align="left" rowspan="1" colspan="1">440 (10.2)</td>
                          <td align="left" rowspan="1" colspan="1">15 (0.4)</td>
                          <td align="left" rowspan="1" colspan="1">0.05</td>
                          <td align="left" rowspan="1" colspan="1">Additive</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">
                            <bold>rs5065</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">11846011</td>
                          <td align="left" rowspan="1" colspan="1">A/G</td>
                          <td align="left" rowspan="1" colspan="1">3187 (74.1)</td>
                          <td align="left" rowspan="1" colspan="1">996 (23.2)</td>
                          <td align="left" rowspan="1" colspan="1">117 (2.7)</td>
                          <td align="left" rowspan="1" colspan="1">0.14</td>
                          <td align="left" rowspan="1" colspan="1">Additive</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">
                            <bold>rs5063</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">11847591</td>
                          <td align="left" rowspan="1" colspan="1">G/A</td>
                          <td align="left" rowspan="1" colspan="1">3906 (90.8)</td>
                          <td align="left" rowspan="1" colspan="1">382 (8.9)</td>
                          <td align="left" rowspan="1" colspan="1">12 (0.3)</td>
                          <td align="left" rowspan="1" colspan="1">0.05</td>
                          <td align="left" rowspan="1" colspan="1">Additive</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">
                            <bold>rs41300100</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">11848089</td>
                          <td align="left" rowspan="1" colspan="1">C/G</td>
                          <td align="left" rowspan="1" colspan="1">4218 (98.3)</td>
                          <td align="left" rowspan="1" colspan="1">74 (1.7)</td>
                          <td align="left" rowspan="1" colspan="1">1 (0.02)</td>
                          <td align="left" rowspan="1" colspan="1">0.01</td>
                          <td align="left" rowspan="1" colspan="1">Dominant</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">
                            <bold>rs17376426</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">11848110</td>
                          <td align="left" rowspan="1" colspan="1">C/T</td>
                          <td align="left" rowspan="1" colspan="1">3999 (93.0)</td>
                          <td align="left" rowspan="1" colspan="1">296 (6.9)</td>
                          <td align="left" rowspan="1" colspan="1">3 (0.1)</td>
                          <td align="left" rowspan="1" colspan="1">0.04</td>
                          <td align="left" rowspan="1" colspan="1">Dominant</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">
                            <bold>rs198372</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">11849457</td>
                          <td align="left" rowspan="1" colspan="1">G/A</td>
                          <td align="left" rowspan="1" colspan="1">3166 (73.6)</td>
                          <td align="left" rowspan="1" colspan="1">1029 (24.0)</td>
                          <td align="left" rowspan="1" colspan="1">105 (2.4)</td>
                          <td align="left" rowspan="1" colspan="1">0.14</td>
                          <td align="left" rowspan="1" colspan="1">Additive</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">
                            <bold>rs632793</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">11850620</td>
                          <td align="left" rowspan="1" colspan="1">A/G</td>
                          <td align="left" rowspan="1" colspan="1">1488 (34.6)</td>
                          <td align="left" rowspan="1" colspan="1">2082 (48.4)</td>
                          <td align="left" rowspan="1" colspan="1">728 (16.9)</td>
                          <td align="left" rowspan="1" colspan="1">0.41</td>
                          <td align="left" rowspan="1" colspan="1">Additive</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">
                            <bold>rs6541007</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">11857407</td>
                          <td align="left" rowspan="1" colspan="1">G/A</td>
                          <td align="left" rowspan="1" colspan="1">4119 (95.8)</td>
                          <td align="left" rowspan="1" colspan="1">180 (4.2)</td>
                          <td align="left" rowspan="1" colspan="1">2 (0.05)</td>
                          <td align="left" rowspan="1" colspan="1">0.02</td>
                          <td align="left" rowspan="1" colspan="1">Dominant</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">
                            <bold>rs5229</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">11858462</td>
                          <td align="left" rowspan="1" colspan="1">G/A</td>
                          <td align="left" rowspan="1" colspan="1">4179 (98.1)</td>
                          <td align="left" rowspan="1" colspan="1">82 (1.9)</td>
                          <td align="left" rowspan="1" colspan="1">0 (0.0)</td>
                          <td align="left" rowspan="1" colspan="1">0.01</td>
                          <td align="left" rowspan="1" colspan="1">Dominant</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                  <table-wrap-foot>
                    <fn id="t001fn001">
                      <p>*sorted in 5’ to 3’ direction based on human genome GRCh38.p13.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
              <sec id="sec009">
                <title>Other measurements</title>
                <p>Standing height was measured to the nearest 0.1 cm with a Handi-stat set square (Perspective Enterprises, Portage, MI) and the average of four measurements was used in analysis. Weight was measured to the nearest 0.1 kg with an electronic digital scale (SECA 841, Hanover, MD). Body mass index (BMI) was calculated from these measurements as weight (kg)/height (m)<sup>2</sup>. Centrally trained research assistants measured sitting blood pressure using the average of three readings from an automated blood pressure machine (BP-tru BPM 300, VMS Medtech, Coquitlam, Canada). Hypertension was defined as SBP ≥ 130 mmHg or DBP ≥ 80 mmHg during the LLFS examination or current use of anti-hypertension medication [<xref rid="pone.0248726.ref018" ref-type="bibr">18</xref>]. Participant history of (atrial fibrillation) AF and myocardial infarction (MI) were determined by self-report during the interview process and included collection of information regarding treatment or hospitalization, if applicable.</p>
              </sec>
              <sec id="sec010">
                <title>Statistical analysis</title>
                <p>All analyses were performed using the Sequential Oligogenic Linkage Analysis (SOLAR) program, which applies a variance-covariance method to adjust for family structure [<xref rid="pone.0248726.ref021" ref-type="bibr">21</xref>]. We defined outliers for NT-proBNP as +/- 4SD from the mean and excluded one observation (value = 27,950 pg/ml). We then log-transformed the NT-proBNP values to conform to the assumption of normal distribution as required by the SOLAR program. All analyses were adjusted for age, sex, and field center and used an alpha of 0.05 as a threshold for nominal significance, but also assessed Bonferroni-corrected alpha levels, as described below. Other potential risk factors for CVD, such as BMI, smoking, lipoprotein levels, and diabetes were considered to be potentially in the causal pathway and were not included as adjustment factors in order to not over-adjust the associations. We used multiple linear regressions to test the association of our selected SNPs (predictors) and logNT-proBNP (outcome), first as individual SNPs and then as SNPs combined into a single model in order to identify SNPs with independent associations with NT-proBNP (Bonferroni corrected alpha for 10 SNPs = 0.005).</p>
                <p>We tested the association of SNPs that were associated with NT-proBNP level with individual CVD related measures and risk factors (Bonferroni corrected alpha for 7 SNPs = 0.007) including blood pressures, prevalent hypertension, BMI, history of AF, and history of MI. Lastly, for all significant models after Bonferroni correction, we ran additional analyses including adjustment for NT-proBNP level in order to determine if the significant genetic association was partially driven by NT-proBNP level itself. We also conducted sensitivity analyses among individuals of either generation who had NT-proBNP levels in the normal range defined as: &lt;125pg/ml in those aged &lt;75 years, and &lt;450pg/ml in individuals aged ≥75years (N = 3,309) [<xref rid="pone.0248726.ref022" ref-type="bibr">22</xref>]. Lastly, given the wide age range and global distribution of the LLFS, we also performed stratified analyses and tested for interaction by familial generation (proband generation and offspring generation) and country (US versus Denmark).</p>
              </sec>
            </sec>
            <sec sec-type="results" id="sec011">
              <title>Results</title>
              <sec id="sec012">
                <title>Characteristics of LLFS population</title>
                <p>The 4,331 participants from the LLFS in this analysis consisted of 55.4% females and were aged 69.8 years (24–110) on average (<xref rid="pone.0248726.t002" ref-type="table">Table 2</xref>). Of the 4,331 participants, 1,385 were in the proband generation (49–110), while 2,946 were in the offspring generation (24–88). Approximately 6% of participants had a history of AF and 5% had a history of MI. The average systolic blood pressure (SBP) and diastolic blood pressure (DBP) were 131.8 mmHg and 77.5 mmHg, respectively. 55% percent of participants had hypertension and 80% were on anti-hypertensive therapy. The median level of NT-proBNP was 86 pg/ml. After adjusting for age, sex, and field center, the residual heritability of NT-proBNP was 0.21 (p = 4 × 10<sup>−14</sup>).</p>
                <table-wrap id="pone.0248726.t002" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0248726.t002</object-id>
                  <label>Table 2</label>
                  <caption>
                    <title>Basic characteristics of the LLFS by generation.</title>
                  </caption>
                  <alternatives>
                    <graphic id="pone.0248726.t002g" xlink:href="pone.0248726.t002"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="left" colspan="2" style="background-color:#D9D9D9" rowspan="1">Characteristic</th>
                          <th align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">All LLFS</th>
                          <th align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">Proband Generation </th>
                          <th align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">Offspring Generation</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" colspan="2" style="background-color:#D9D9D9" rowspan="1">Total Participants</td>
                          <td align="left" rowspan="1" colspan="1">4331</td>
                          <td align="left" rowspan="1" colspan="1">1385</td>
                          <td align="left" rowspan="1" colspan="1">2946</td>
                        </tr>
                        <tr>
                          <td align="left" colspan="2" style="background-color:#D9D9D9" rowspan="1">Age (mean ± SD)</td>
                          <td align="left" rowspan="1" colspan="1">69.8 ± 15.5</td>
                          <td align="left" rowspan="1" colspan="1">89.2 ± 6.9</td>
                          <td align="left" rowspan="1" colspan="1">60.6 ± 8.3</td>
                        </tr>
                        <tr>
                          <td align="left" colspan="2" style="background-color:#D9D9D9" rowspan="1">Female n (%)</td>
                          <td align="left" rowspan="1" colspan="1">2398 (55.4)</td>
                          <td align="left" rowspan="1" colspan="1">755 (54.51)</td>
                          <td align="left" rowspan="1" colspan="1">1643 (55.8)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="4" style="background-color:#D9D9D9" colspan="1">Field Center n (%) </td>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">Denmark</td>
                          <td align="left" rowspan="1" colspan="1">1163 (26.9)</td>
                          <td align="left" rowspan="1" colspan="1">203 (14.7)</td>
                          <td align="left" rowspan="1" colspan="1">960 (32.6)</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">Boston</td>
                          <td align="left" rowspan="1" colspan="1">1165 (26.9)</td>
                          <td align="left" rowspan="1" colspan="1">367 (25.5)</td>
                          <td align="left" rowspan="1" colspan="1">798 (27.1)</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">New York</td>
                          <td align="left" rowspan="1" colspan="1">863 (19.9)</td>
                          <td align="left" rowspan="1" colspan="1">408 (29.5)</td>
                          <td align="left" rowspan="1" colspan="1">455 (15.4)</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">Pittsburgh</td>
                          <td align="left" rowspan="1" colspan="1">1140 (26.3)</td>
                          <td align="left" rowspan="1" colspan="1">407 (29.4)</td>
                          <td align="left" rowspan="1" colspan="1">733 (24.9)</td>
                        </tr>
                        <tr>
                          <td align="left" colspan="2" style="background-color:#D9D9D9" rowspan="1">BMI (kg/m<sup>2</sup>) mean ± SD</td>
                          <td align="left" rowspan="1" colspan="1">27.1 ± 4.8</td>
                          <td align="left" rowspan="1" colspan="1">26.1 ± 4.2</td>
                          <td align="left" rowspan="1" colspan="1">27.5 ± 4.9</td>
                        </tr>
                        <tr>
                          <td align="left" colspan="2" style="background-color:#D9D9D9" rowspan="1">SBP (mmHg) mean ± SD</td>
                          <td align="left" rowspan="1" colspan="1">131.8 ± 22.2</td>
                          <td align="left" rowspan="1" colspan="1">139.2 ± 25.3</td>
                          <td align="left" rowspan="1" colspan="1">128.4 ± 19.7</td>
                        </tr>
                        <tr>
                          <td align="left" colspan="2" style="background-color:#D9D9D9" rowspan="1">DBP (mmHg) mean ± SD</td>
                          <td align="left" rowspan="1" colspan="1">77.5 ± 11.4</td>
                          <td align="left" rowspan="1" colspan="1">74.0 ± 11.7</td>
                          <td align="left" rowspan="1" colspan="1">79.1 ± 10.9</td>
                        </tr>
                        <tr>
                          <td align="left" colspan="2" style="background-color:#D9D9D9" rowspan="1">Hypertension n (%)</td>
                          <td align="left" rowspan="1" colspan="1">3166 (73.1)</td>
                          <td align="left" rowspan="1" colspan="1">1189 (85.9)</td>
                          <td align="left" rowspan="1" colspan="1">1977 (67.1)</td>
                        </tr>
                        <tr>
                          <td align="left" colspan="2" style="background-color:#D9D9D9" rowspan="1">Diabetes n (%)</td>
                          <td align="left" rowspan="1" colspan="1">300 (6.9)</td>
                          <td align="left" rowspan="1" colspan="1">131 (9.5)</td>
                          <td align="left" rowspan="1" colspan="1">169 (5.7)</td>
                        </tr>
                        <tr>
                          <td align="left" colspan="2" style="background-color:#D9D9D9" rowspan="1">Atrial Fibrillation n (%)</td>
                          <td align="left" rowspan="1" colspan="1">242 (5.6)</td>
                          <td align="left" rowspan="1" colspan="1">175 (12.7)</td>
                          <td align="left" rowspan="1" colspan="1">67 (2.3)</td>
                        </tr>
                        <tr>
                          <td align="left" colspan="2" style="background-color:#D9D9D9" rowspan="1">Myocardial Infarction n (%)</td>
                          <td align="left" rowspan="1" colspan="1">213 (4.9)</td>
                          <td align="left" rowspan="1" colspan="1">129 (9.3)</td>
                          <td align="left" rowspan="1" colspan="1">84 (2.9)</td>
                        </tr>
                        <tr>
                          <td align="left" colspan="2" style="background-color:#D9D9D9" rowspan="1">NT-proBNP (pg/ml) median (range)</td>
                          <td align="left" rowspan="1" colspan="1">86.0 (5–14739)</td>
                          <td align="left" rowspan="1" colspan="1">341 (5–14739)</td>
                          <td align="left" rowspan="1" colspan="1">54 (5–5310)</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                  <table-wrap-foot>
                    <fn id="t002fn001">
                      <p>BMI: Body Mass Index, NT-proBNP: N-Terminal pro-BNP, SBP: Systolic Blood Pressure, DBP: Diastolic Blood Pressure.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
              <sec id="sec013">
                <title>Associations of SNPs with NT-proBNP level</title>
                <p>Genotype information for the 10 SNPs in the <italic>NPPA/NPPB</italic> region used in this analysis are listed in <xref rid="pone.0248726.t001" ref-type="table">Table 1</xref>. Seven of these SNPs showed nominally significant associations with NT-proBNP level (all P&lt;0.05; <xref rid="pone.0248726.t003" ref-type="table">Table 3</xref>). Entered together into a single model, these 7 SNPs accounted for 0.85% of the variance in NT-proBNP level. However, only 2 SNPs were independently associated with NT-proBNP level: rs632792 (additive β = 0.16, p&lt;0.001) and rs41300100 (dominant β = 0.26, p = 0.05; <xref rid="pone.0248726.t003" ref-type="table">Table 3</xref>). On average, for each copy of the G allele at rs632793, individuals had 3.5% greater NT-proBNP than individuals with the AA genotype. Additionally, individuals with 1 or more A allele at rs41300100 had 5.7% greater NT-proBNP than those with the GG genotype.</p>
                <table-wrap id="pone.0248726.t003" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0248726.t003</object-id>
                  <label>Table 3</label>
                  <caption>
                    <title>Association between SNPs and NT-proBNP level.</title>
                  </caption>
                  <alternatives>
                    <graphic id="pone.0248726.t003g" xlink:href="pone.0248726.t003"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="left" rowspan="2" style="background-color:#D9D9D9" colspan="1"> SNPs</th>
                          <th align="left" colspan="2" style="background-color:#D9D9D9" rowspan="1">Univariate</th>
                          <th align="left" colspan="2" style="background-color:#D9D9D9" rowspan="1">Independently Significant SNP</th>
                        </tr>
                        <tr>
                          <th align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">β</th>
                          <th align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">P-value</th>
                          <th align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">β</th>
                          <th align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">P-value</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">
                            <bold>rs198358</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">0.11</td>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>&lt;0.001</bold>
                            <xref ref-type="table-fn" rid="t003fn003">*</xref>
                          </td>
                          <td align="left" rowspan="1" colspan="1">-0.03</td>
                          <td align="left" rowspan="1" colspan="1">0.43</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">
                            <bold>rs5068</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">0.12</td>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>0.01</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">0.06</td>
                          <td align="left" rowspan="1" colspan="1">0.33</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">
                            <bold>rs5065</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">0.03</td>
                          <td align="left" rowspan="1" colspan="1">0.31</td>
                          <td align="left" rowspan="1" colspan="1"> </td>
                          <td align="left" rowspan="1" colspan="1"> </td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">
                            <bold>rs5063</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">0.24</td>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>&lt;0.001</bold>
                            <xref ref-type="table-fn" rid="t003fn003">*</xref>
                          </td>
                          <td align="left" rowspan="1" colspan="1">0.13</td>
                          <td align="left" rowspan="1" colspan="1">0.06</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">
                            <bold>rs41300100</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">0.47</td>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>&lt;0.001</bold>
                            <xref ref-type="table-fn" rid="t003fn003">*</xref>
                          </td>
                          <td align="left" rowspan="1" colspan="1">0.26</td>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>0.05</bold>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">
                            <bold>rs17376426</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">0.12</td>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>0.04</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">-0.09</td>
                          <td align="left" rowspan="1" colspan="1">0.14</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">
                            <bold>rs198372</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">0.06</td>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>0.04</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">-0.02</td>
                          <td align="left" rowspan="1" colspan="1">0.6</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">
                            <bold>rs632793</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">0.17</td>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>&lt;0.001</bold>
                            <xref ref-type="table-fn" rid="t003fn003">*</xref>
                          </td>
                          <td align="left" rowspan="1" colspan="1">0.16</td>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>&lt;0.001</bold>
                            <xref ref-type="table-fn" rid="t003fn003">*</xref>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">
                            <bold>rs6541007</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">-0.05</td>
                          <td align="left" rowspan="1" colspan="1">0.55</td>
                          <td align="left" rowspan="1" colspan="1"> </td>
                          <td align="left" rowspan="1" colspan="1"> </td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">
                            <bold>rs5229</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">-0.03</td>
                          <td align="left" rowspan="1" colspan="1">0.82</td>
                          <td align="left" rowspan="1" colspan="1"> </td>
                          <td align="left" rowspan="1" colspan="1"> </td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                  <table-wrap-foot>
                    <fn id="t003fn001">
                      <p>NT-proBNP was modeled as the outcome and the SNPs were the predictors, adjusting for age, sex, study center. For Univariate results, each SNP was tested alone in a single model. Then SNPs that were significant in Univariate analyses were combined together into a single model to determine SNPs with independent effects on NT-proBNP level.</p>
                    </fn>
                    <fn id="t003fn002">
                      <p><bold>BOLD</bold> signifies P&lt;0.05</p>
                    </fn>
                    <fn id="t003fn003">
                      <p>*denotes passing Bonferroni correction threshold.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
              <sec id="sec014">
                <title>Association of NT-proBNP with prevalent CVD measures</title>
                <p>Associations between NT-proBNP level and CVD related measures are shown in <xref ref-type="supplementary-material" rid="pone.0248726.s001">S1 Table</xref>. NT-proBNP level was positively associated with age (p = 1 × 10<sup>−307</sup>), such that a 1 unit greater logNT-proBNP (~2.72 pg/ml) was associated with ~8 years greater age after adjusting for sex and study center. After adjusting for age and study center, 1 log(pg/ml) increased logNT-proBNP was associated with 20% greater odds of being male (P = 1×10<sup>−17</sup>). After full adjustment for age, sex, and study center, 1 unit increased NT-proBNP was associated with 0.53 mmHg decreased diastolic blood pressure (p = 0.002), 0.12 kg/m<sup>2</sup> decreased BMI, 45% decreased odds of having AF history, and 22% decreased odds of MI history (all P&lt;0.001).</p>
              </sec>
              <sec id="sec015">
                <title>Association of SNPs with prevalent CVD measures</title>
                <p>Associations between the 7 SNPs individually associated with NT-proBNP levels and CVD measures are shown in <xref rid="pone.0248726.t004" ref-type="table">Table 4</xref>. The minor allele of rs632793 was nominally associated with AF, such that the presence of each G allele was associated with an additional 10% lower odds of a history of AF compared to individuals with the AA genotype (P = 0.030). Also, the minor (G) allele of rs632793 was associated with lower SBP (β = -1.3, p = 0.0095) and DBP (β = -0.6, p = 0.018), but no significant association with prevalent hypertension when defined by blood pressures or medication status (p = 0.807).</p>
                <table-wrap id="pone.0248726.t004" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0248726.t004</object-id>
                  <label>Table 4</label>
                  <caption>
                    <title>Association between CVD measures and SNPs associated with BNP level.</title>
                  </caption>
                  <alternatives>
                    <graphic id="pone.0248726.t004g" xlink:href="pone.0248726.t004"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="left" rowspan="2" style="background-color:#D9D9D9" colspan="1">SNP</th>
                          <th align="left" colspan="2" style="background-color:#D9D9D9" rowspan="1">BMI</th>
                          <th align="left" colspan="2" style="background-color:#D9D9D9" rowspan="1">SBP</th>
                          <th align="left" colspan="2" style="background-color:#D9D9D9" rowspan="1">DBP</th>
                          <th align="left" colspan="2" style="background-color:#D9D9D9" rowspan="1">Hypertension</th>
                          <th align="left" colspan="2" style="background-color:#D9D9D9" rowspan="1">AF</th>
                          <th align="left" colspan="2" style="background-color:#D9D9D9" rowspan="1">MI</th>
                        </tr>
                        <tr>
                          <th align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">β</th>
                          <th align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">P</th>
                          <th align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">β</th>
                          <th align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">P</th>
                          <th align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">β</th>
                          <th align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">P</th>
                          <th align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">β</th>
                          <th align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">P</th>
                          <th align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">β</th>
                          <th align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">P</th>
                          <th align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">β</th>
                          <th align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">P</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">rs198358</td>
                          <td align="right" rowspan="1" colspan="1">-0.04</td>
                          <td align="right" rowspan="1" colspan="1">0.15</td>
                          <td align="right" rowspan="1" colspan="1">0.14</td>
                          <td align="right" rowspan="1" colspan="1">0.8</td>
                          <td align="right" rowspan="1" colspan="1">-0.04</td>
                          <td align="right" rowspan="1" colspan="1">0.9</td>
                          <td align="right" rowspan="1" colspan="1">0.03</td>
                          <td align="right" rowspan="1" colspan="1">0.39</td>
                          <td align="right" rowspan="1" colspan="1">-0.09</td>
                          <td align="right" rowspan="1" colspan="1">0.09</td>
                          <td align="right" rowspan="1" colspan="1">-0.02</td>
                          <td align="right" rowspan="1" colspan="1">0.7</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">rs5068</td>
                          <td align="right" rowspan="1" colspan="1">0.02</td>
                          <td align="right" rowspan="1" colspan="1">0.64</td>
                          <td align="right" rowspan="1" colspan="1">-1.05</td>
                          <td align="right" rowspan="1" colspan="1">0.32</td>
                          <td align="right" rowspan="1" colspan="1">0.21</td>
                          <td align="right" rowspan="1" colspan="1">0.7</td>
                          <td align="right" rowspan="1" colspan="1">0.04</td>
                          <td align="right" rowspan="1" colspan="1">0.53</td>
                          <td align="right" rowspan="1" colspan="1">-0.14</td>
                          <td align="right" rowspan="1" colspan="1">0.18</td>
                          <td align="right" rowspan="1" colspan="1">0.02</td>
                          <td align="right" rowspan="1" colspan="1">1</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">rs5063</td>
                          <td align="right" rowspan="1" colspan="1">-0.06</td>
                          <td align="right" rowspan="1" colspan="1">0.27</td>
                          <td align="right" rowspan="1" colspan="1">0.36</td>
                          <td align="right" rowspan="1" colspan="1">0.75</td>
                          <td align="right" rowspan="1" colspan="1">-0.9</td>
                          <td align="right" rowspan="1" colspan="1">0.13</td>
                          <td align="right" rowspan="1" colspan="1">-0.01</td>
                          <td align="right" rowspan="1" colspan="1">0.9</td>
                          <td align="right" rowspan="1" colspan="1">0.05</td>
                          <td align="right" rowspan="1" colspan="1">0.69</td>
                          <td align="right" rowspan="1" colspan="1">-0.1</td>
                          <td align="right" rowspan="1" colspan="1">0.37</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">rs41300100</td>
                          <td align="right" rowspan="1" colspan="1">0.07</td>
                          <td align="right" rowspan="1" colspan="1">0.57</td>
                          <td align="right" rowspan="1" colspan="1">-1.08</td>
                          <td align="right" rowspan="1" colspan="1">0.67</td>
                          <td align="right" rowspan="1" colspan="1">-0.78</td>
                          <td align="right" rowspan="1" colspan="1">0.56</td>
                          <td align="right" rowspan="1" colspan="1">-0.07</td>
                          <td align="right" rowspan="1" colspan="1">0.7</td>
                          <td align="right" rowspan="1" colspan="1">-0.07</td>
                          <td align="right" rowspan="1" colspan="1">0.79</td>
                          <td align="right" rowspan="1" colspan="1">0.36</td>
                          <td align="right" rowspan="1" colspan="1">0.23</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">rs17376426</td>
                          <td align="right" rowspan="1" colspan="1">0.04</td>
                          <td align="right" rowspan="1" colspan="1">0.54</td>
                          <td align="right" rowspan="1" colspan="1">-0.22</td>
                          <td align="right" rowspan="1" colspan="1">0.87</td>
                          <td align="right" rowspan="1" colspan="1">0.93</td>
                          <td align="right" rowspan="1" colspan="1">0.17</td>
                          <td align="right" rowspan="1" colspan="1">-0.01</td>
                          <td align="right" rowspan="1" colspan="1">0.88</td>
                          <td align="right" rowspan="1" colspan="1">-0.01</td>
                          <td align="right" rowspan="1" colspan="1">0.93</td>
                          <td align="right" rowspan="1" colspan="1">0.02</td>
                          <td align="right" rowspan="1" colspan="1">0.98</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">rs198372</td>
                          <td align="right" rowspan="1" colspan="1">-0.03</td>
                          <td align="right" rowspan="1" colspan="1">0.44</td>
                          <td align="right" rowspan="1" colspan="1">-0.64</td>
                          <td align="right" rowspan="1" colspan="1">0.34</td>
                          <td align="right" rowspan="1" colspan="1">-0.4</td>
                          <td align="right" rowspan="1" colspan="1">0.25</td>
                          <td align="right" rowspan="1" colspan="1">0.03</td>
                          <td align="right" rowspan="1" colspan="1">0.55</td>
                          <td align="right" rowspan="1" colspan="1">-0.01</td>
                          <td align="right" rowspan="1" colspan="1">0.89</td>
                          <td align="right" rowspan="1" colspan="1">-0.03</td>
                          <td align="right" rowspan="1" colspan="1">0.69</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">rs632793</td>
                          <td align="right" rowspan="1" colspan="1">-0.02</td>
                          <td align="right" rowspan="1" colspan="1">0.36</td>
                          <td align="right" rowspan="1" colspan="1">-1.25</td>
                          <td align="right" rowspan="1" colspan="1">
                            <bold>0.01</bold>
                          </td>
                          <td align="right" rowspan="1" colspan="1">-0.59</td>
                          <td align="right" rowspan="1" colspan="1">
                            <bold>0.018</bold>
                          </td>
                          <td align="right" rowspan="1" colspan="1">0.01</td>
                          <td align="right" rowspan="1" colspan="1">0.81</td>
                          <td align="right" rowspan="1" colspan="1">-0.11</td>
                          <td align="right" rowspan="1" colspan="1">
                            <bold>0.03</bold>
                          </td>
                          <td align="right" rowspan="1" colspan="1">0</td>
                          <td align="right" rowspan="1" colspan="1">0.89</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                  <table-wrap-foot>
                    <fn id="t004fn001">
                      <p>Adjusted for age, sex, and study center.</p>
                    </fn>
                    <fn id="t004fn002">
                      <p><bold>BOLD</bold> signifies P&lt;0.05.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <p>After further adjusting significant associations for NT-proBNP level, the association between the minor allele of rs632793 and AF was attenuated (β = -0.07; p = 0.180), while its associationwith lower SBP and DBP remained significant (P&lt;0.04; <xref ref-type="supplementary-material" rid="pone.0248726.s005">S5 Table</xref>). In sensitivity analyses conducted only in individuals with NT-proBNP levels in the normal range (N = 3309), the results were largely similar for all analyses (<xref ref-type="supplementary-material" rid="pone.0248726.s002">S2</xref>–<xref ref-type="supplementary-material" rid="pone.0248726.s004">S4</xref> Tables).</p>
              </sec>
              <sec id="sec016">
                <title>Stratified analyses</title>
                <p>Compared to the proband generation, the offspring generation had a greater number of significant associations between SNPs and NT-proBNP level (<xref rid="pone.0248726.t005" ref-type="table">Table 5</xref>). In addition to rs632793, rs17376426 was significantly and independently associated with NT-proBNP levels in the offspring generation. While there was significant interaction by generation for rs198358 and rs5065 (both P<sub>interaction</sub> &lt;0.05), the effect of rs632793 on levels of NT-proBNP was similar across generations (P<sub>interaction</sub> = 0.09). However, the associations of SNPs with CVD measures (<xref rid="pone.0248726.t006" ref-type="table">Table 6</xref>) were predominantly seen in the proband generation, without any significant findings in the offspring who had less CVD burden in general (<xref rid="pone.0248726.t002" ref-type="table">Table 2</xref>). Similar to results in all LLFS, rs632793 was inversely associated with SBP and DBP, although the association with AF was not significant in either single generation subset (<xref rid="pone.0248726.t006" ref-type="table">Table 6</xref>). These generation-specific effects for rs632793 are suggestive of a significant interaction by generation on blood pressures (P<sub>interaction</sub>&lt;0.05; <xref ref-type="supplementary-material" rid="pone.0248726.s006">S6 Table</xref>). Additionally, rs41300100 was significantly associated with hypertension (β = -4.06, p = 0.006, <xref rid="pone.0248726.t006" ref-type="table">Table 6</xref>) in the proband generation, alone; however this effect did not reflect significant interaction by generation (<xref ref-type="supplementary-material" rid="pone.0248726.s006">S6 Table</xref>).</p>
                <table-wrap id="pone.0248726.t005" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0248726.t005</object-id>
                  <label>Table 5</label>
                  <caption>
                    <title>Association of BNP variants with NT-proBNP level stratified by LLFS generation.</title>
                  </caption>
                  <alternatives>
                    <graphic id="pone.0248726.t005g" xlink:href="pone.0248726.t005"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="left" rowspan="2" style="background-color:#D9D9D9" colspan="1"> SNPs</th>
                          <th align="left" colspan="2" style="background-color:#D9D9D9" rowspan="1">Proband Generation</th>
                          <th align="left" colspan="2" style="background-color:#D9D9D9" rowspan="1">Offspring Generation</th>
                          <th align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">Interaction</th>
                        </tr>
                        <tr>
                          <th align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">β</th>
                          <th align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">P-value</th>
                          <th align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">β</th>
                          <th align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">P-value</th>
                          <th align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">P-value</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">
                            <bold>rs198358</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">0.006</td>
                          <td align="left" rowspan="1" colspan="1">0.9</td>
                          <td align="left" rowspan="1" colspan="1">0.16</td>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>&lt;0.001</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>0.01</bold>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">
                            <bold>rs5068</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">0.03</td>
                          <td align="left" rowspan="1" colspan="1">0.71</td>
                          <td align="left" rowspan="1" colspan="1">0.16</td>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>0.003</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">0.25</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">
                            <bold>rs5065</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">-0.08</td>
                          <td align="left" rowspan="1" colspan="1">0.15</td>
                          <td align="left" rowspan="1" colspan="1">0.08</td>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>0.03</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>0.03</bold>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">
                            <bold>rs5063</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">0.28</td>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>0.004</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">0.25</td>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>&lt;0.001</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">0.84</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">
                            <bold>rs41300100</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">0.45</td>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>0.05</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">0.47</td>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>&lt;0.001</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">0.85</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">
                            <bold>rs17376426</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">0.18</td>
                          <td align="left" rowspan="1" colspan="1">0.17</td>
                          <td align="left" rowspan="1" colspan="1">-0.21</td>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>0.002</bold>
                            <xref ref-type="table-fn" rid="t005fn002">*</xref>
                          </td>
                          <td align="left" rowspan="1" colspan="1">0.08</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">
                            <bold>rs198372</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">-0.03</td>
                          <td align="left" rowspan="1" colspan="1">0.64</td>
                          <td align="left" rowspan="1" colspan="1">0.09</td>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>0.007</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">0.13</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">
                            <bold>rs632793</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">0.1</td>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>0.01</bold>
                            <xref ref-type="table-fn" rid="t005fn002">*</xref>
                          </td>
                          <td align="left" rowspan="1" colspan="1">0.19</td>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>&lt;0.001</bold>
                            <xref ref-type="table-fn" rid="t005fn002">*</xref>
                          </td>
                          <td align="left" rowspan="1" colspan="1">0.09</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">
                            <bold>rs6541007</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">-0.06</td>
                          <td align="left" rowspan="1" colspan="1">0.7</td>
                          <td align="left" rowspan="1" colspan="1">0.04</td>
                          <td align="left" rowspan="1" colspan="1">0.62</td>
                          <td align="left" rowspan="1" colspan="1">0.41</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">
                            <bold>rs5229</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">-0.08</td>
                          <td align="left" rowspan="1" colspan="1">0.66</td>
                          <td align="left" rowspan="1" colspan="1">-0.04</td>
                          <td align="left" rowspan="1" colspan="1">0.78</td>
                          <td align="left" rowspan="1" colspan="1">0.90</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                  <table-wrap-foot>
                    <fn id="t005fn001">
                      <p>All models adjusted for age, sex, and study center.</p>
                    </fn>
                    <fn id="t005fn002">
                      <p>* Indicates SNPs with independent effects after combining SNPs with individual P-value&lt;0.1 together into a single model.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <table-wrap id="pone.0248726.t006" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0248726.t006</object-id>
                  <label>Table 6</label>
                  <caption>
                    <title>Association of BNP variants with CVD measures stratified by LLFS generation.</title>
                  </caption>
                  <alternatives>
                    <graphic id="pone.0248726.t006g" xlink:href="pone.0248726.t006"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="left" rowspan="2" style="background-color:#D9D9D9" colspan="1">NT-proBNP Associated SNP</th>
                          <th align="left" colspan="2" style="background-color:#D9D9D9" rowspan="1">BMI</th>
                          <th align="left" colspan="2" style="background-color:#D9D9D9" rowspan="1">SBP</th>
                          <th align="left" colspan="2" style="background-color:#D9D9D9" rowspan="1">DBP</th>
                          <th align="left" colspan="2" style="background-color:#D9D9D9" rowspan="1">Hypertension</th>
                          <th align="left" colspan="2" style="background-color:#D9D9D9" rowspan="1">AF</th>
                          <th align="left" colspan="2" style="background-color:#D9D9D9" rowspan="1">MI</th>
                        </tr>
                        <tr>
                          <th align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">β</th>
                          <th align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">P</th>
                          <th align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">β</th>
                          <th align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">P</th>
                          <th align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">β</th>
                          <th align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">P</th>
                          <th align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">β</th>
                          <th align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">P</th>
                          <th align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">β</th>
                          <th align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">P</th>
                          <th align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">β</th>
                          <th align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">P</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">
                            <bold>Proband </bold>
                          </td>
                          <td align="left" colspan="12" rowspan="1"> </td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">
                            <bold>rs5063</bold>
                          </td>
                          <td align="right" rowspan="1" colspan="1">-0.08</td>
                          <td align="right" rowspan="1" colspan="1">0.38</td>
                          <td align="right" rowspan="1" colspan="1">2.02</td>
                          <td align="right" rowspan="1" colspan="1">0.4</td>
                          <td align="right" rowspan="1" colspan="1">-1.3</td>
                          <td align="right" rowspan="1" colspan="1">0.25</td>
                          <td align="right" rowspan="1" colspan="1">-0.32</td>
                          <td align="right" rowspan="1" colspan="1">0.06</td>
                          <td align="right" rowspan="1" colspan="1">-0.09</td>
                          <td align="right" rowspan="1" colspan="1">0.57</td>
                          <td align="right" rowspan="1" colspan="1">-0.16</td>
                          <td align="right" rowspan="1" colspan="1">0.32</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">
                            <bold>rs41300100</bold>
                          </td>
                          <td align="right" rowspan="1" colspan="1">-0.13</td>
                          <td align="right" rowspan="1" colspan="1">0.56</td>
                          <td align="right" rowspan="1" colspan="1">0.64</td>
                          <td align="right" rowspan="1" colspan="1">0.91</td>
                          <td align="right" rowspan="1" colspan="1">-0.46</td>
                          <td align="right" rowspan="1" colspan="1">0.86</td>
                          <td align="right" rowspan="1" colspan="1">-4.06</td>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>0.006</bold>
                            <xref ref-type="table-fn" rid="t006fn002">*</xref>
                          </td>
                          <td align="right" rowspan="1" colspan="1">-0.23</td>
                          <td align="right" rowspan="1" colspan="1">0.49</td>
                          <td align="right" rowspan="1" colspan="1">0.42</td>
                          <td align="right" rowspan="1" colspan="1">0.34</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">
                            <bold>rs632793</bold>
                          </td>
                          <td align="right" rowspan="1" colspan="1">0.02</td>
                          <td align="right" rowspan="1" colspan="1">0.55</td>
                          <td align="right" rowspan="1" colspan="1">-2.72</td>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>0.007</bold>
                            <xref ref-type="table-fn" rid="t006fn002">*</xref>
                          </td>
                          <td align="right" rowspan="1" colspan="1">-1.42</td>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>0.003</bold>
                            <xref ref-type="table-fn" rid="t006fn002">*</xref>
                          </td>
                          <td align="right" rowspan="1" colspan="1">-0.06</td>
                          <td align="right" rowspan="1" colspan="1">0.34</td>
                          <td align="right" rowspan="1" colspan="1">-0.08</td>
                          <td align="right" rowspan="1" colspan="1">0.22</td>
                          <td align="right" rowspan="1" colspan="1">0.01</td>
                          <td align="right" rowspan="1" colspan="1">0.92</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">
                            <bold>Offspring</bold>
                          </td>
                          <td align="left" colspan="12" rowspan="1"> </td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">
                            <bold>rs198358</bold>
                          </td>
                          <td align="right" rowspan="1" colspan="1">-0.05</td>
                          <td align="right" rowspan="1" colspan="1">0.1</td>
                          <td align="right" rowspan="1" colspan="1">0.78</td>
                          <td align="right" rowspan="1" colspan="1">0.19</td>
                          <td align="right" rowspan="1" colspan="1">0.31</td>
                          <td align="right" rowspan="1" colspan="1">0.36</td>
                          <td align="right" rowspan="1" colspan="1">0.04</td>
                          <td align="right" rowspan="1" colspan="1">0.35</td>
                          <td align="right" rowspan="1" colspan="1">-0.14</td>
                          <td align="right" rowspan="1" colspan="1">0.11</td>
                          <td align="right" rowspan="1" colspan="1">-0.06</td>
                          <td align="right" rowspan="1" colspan="1">0.48</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">
                            <bold>rs5068</bold>
                          </td>
                          <td align="right" rowspan="1" colspan="1">0.06</td>
                          <td align="right" rowspan="1" colspan="1">0.31</td>
                          <td align="right" rowspan="1" colspan="1">-0.54</td>
                          <td align="right" rowspan="1" colspan="1">0.63</td>
                          <td align="right" rowspan="1" colspan="1">0.5</td>
                          <td align="right" rowspan="1" colspan="1">0.43</td>
                          <td align="right" rowspan="1" colspan="1">0.03</td>
                          <td align="right" rowspan="1" colspan="1">0.75</td>
                          <td align="right" rowspan="1" colspan="1">-0.19</td>
                          <td align="right" rowspan="1" colspan="1">0.22</td>
                          <td align="right" rowspan="1" colspan="1">-0.09</td>
                          <td align="right" rowspan="1" colspan="1">0.53</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">
                            <bold>rs5065</bold>
                          </td>
                          <td align="right" rowspan="1" colspan="1">-0.06</td>
                          <td align="right" rowspan="1" colspan="1">0.12</td>
                          <td align="right" rowspan="1" colspan="1">1.01</td>
                          <td align="right" rowspan="1" colspan="1">0.15</td>
                          <td align="right" rowspan="1" colspan="1">0.31</td>
                          <td align="right" rowspan="1" colspan="1">0.43</td>
                          <td align="right" rowspan="1" colspan="1">0.01</td>
                          <td align="right" rowspan="1" colspan="1">0.87</td>
                          <td align="right" rowspan="1" colspan="1">-0.17</td>
                          <td align="right" rowspan="1" colspan="1">0.08</td>
                          <td align="right" rowspan="1" colspan="1">-0.01</td>
                          <td align="right" rowspan="1" colspan="1">0.89</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">
                            <bold>rs5063</bold>
                          </td>
                          <td align="right" rowspan="1" colspan="1">-0.08</td>
                          <td align="right" rowspan="1" colspan="1">0.2</td>
                          <td align="right" rowspan="1" colspan="1">0.1</td>
                          <td align="right" rowspan="1" colspan="1">0.93</td>
                          <td align="right" rowspan="1" colspan="1">-0.52</td>
                          <td align="right" rowspan="1" colspan="1">0.43</td>
                          <td align="right" rowspan="1" colspan="1">0.06</td>
                          <td align="right" rowspan="1" colspan="1">0.49</td>
                          <td align="right" rowspan="1" colspan="1">0.3</td>
                          <td align="right" rowspan="1" colspan="1">0.14</td>
                          <td align="right" rowspan="1" colspan="1">-0.04</td>
                          <td align="right" rowspan="1" colspan="1">0.93</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">
                            <bold>rs41300100</bold>
                          </td>
                          <td align="right" rowspan="1" colspan="1">0.14</td>
                          <td align="right" rowspan="1" colspan="1">0.34</td>
                          <td align="right" rowspan="1" colspan="1">-0.62</td>
                          <td align="right" rowspan="1" colspan="1">0.82</td>
                          <td align="right" rowspan="1" colspan="1">-0.57</td>
                          <td align="right" rowspan="1" colspan="1">0.71</td>
                          <td align="right" rowspan="1" colspan="1">0.05</td>
                          <td align="right" rowspan="1" colspan="1">0.78</td>
                          <td align="right" rowspan="1" colspan="1">0.22</td>
                          <td align="right" rowspan="1" colspan="1">0.6</td>
                          <td align="right" rowspan="1" colspan="1">0.33</td>
                          <td align="right" rowspan="1" colspan="1">0.46</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">
                            <bold>rs17376426</bold>
                          </td>
                          <td align="right" rowspan="1" colspan="1">0.05</td>
                          <td align="right" rowspan="1" colspan="1">0.51</td>
                          <td align="right" rowspan="1" colspan="1">-0.05</td>
                          <td align="right" rowspan="1" colspan="1">0.97</td>
                          <td align="right" rowspan="1" colspan="1">0.72</td>
                          <td align="right" rowspan="1" colspan="1">0.33</td>
                          <td align="right" rowspan="1" colspan="1">-0.01</td>
                          <td align="right" rowspan="1" colspan="1">0.93</td>
                          <td align="right" rowspan="1" colspan="1">0.002</td>
                          <td align="right" rowspan="1" colspan="1">0.99</td>
                          <td align="right" rowspan="1" colspan="1">-0.04</td>
                          <td align="right" rowspan="1" colspan="1">0.84</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">
                            <bold>rs198372</bold>
                          </td>
                          <td align="right" rowspan="1" colspan="1">-0.04</td>
                          <td align="right" rowspan="1" colspan="1">0.33</td>
                          <td align="right" rowspan="1" colspan="1">0.06</td>
                          <td align="right" rowspan="1" colspan="1">0.93</td>
                          <td align="right" rowspan="1" colspan="1">-0</td>
                          <td align="right" rowspan="1" colspan="1">0.99</td>
                          <td align="right" rowspan="1" colspan="1">0.03</td>
                          <td align="right" rowspan="1" colspan="1">0.6</td>
                          <td align="right" rowspan="1" colspan="1">-0.11</td>
                          <td align="right" rowspan="1" colspan="1">0.29</td>
                          <td align="right" rowspan="1" colspan="1">0.04</td>
                          <td align="right" rowspan="1" colspan="1">0.72</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">
                            <bold>rs632793</bold>
                          </td>
                          <td align="right" rowspan="1" colspan="1">-0.04</td>
                          <td align="right" rowspan="1" colspan="1">0.16</td>
                          <td align="right" rowspan="1" colspan="1">-0.72</td>
                          <td align="right" rowspan="1" colspan="1">0.15</td>
                          <td align="right" rowspan="1" colspan="1">-0.24</td>
                          <td align="right" rowspan="1" colspan="1">0.39</td>
                          <td align="right" rowspan="1" colspan="1">0.03</td>
                          <td align="right" rowspan="1" colspan="1">0.35</td>
                          <td align="right" rowspan="1" colspan="1">-0.14</td>
                          <td align="right" rowspan="1" colspan="1">0.07</td>
                          <td align="right" rowspan="1" colspan="1">0.01</td>
                          <td align="right" rowspan="1" colspan="1">0.85</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                  <table-wrap-foot>
                    <fn id="t006fn001">
                      <p>All models adjusted for age, sex, and study center.</p>
                    </fn>
                    <fn id="t006fn002">
                      <p>* Indicates an association that remained significant (P&lt;0.05) after further adjustment for NT-proBNP level.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <p>Analyses stratified by study center (US versus Denmark) demonstrated similar population characteristics by country (<xref ref-type="supplementary-material" rid="pone.0248726.s007">S7 Table</xref>). Results were also consistent by country for the association of rs632793 and rs41300100 with NT-proBNP level (<xref ref-type="supplementary-material" rid="pone.0248726.s008">S8 Table</xref>) and showed no significant interaction effect by country on the association of BNP SNPs and CVD measures. However, the association between rs632793 and AF appears to be driven by families at the Danish study center (<xref ref-type="supplementary-material" rid="pone.0248726.s008">S8 Table</xref>).</p>
              </sec>
            </sec>
            <sec sec-type="conclusions" id="sec017">
              <title>Discussion</title>
              <p>We found that, in the LLFS, NT-proBNP was significantly heritable (residual heritability estimate (H<sup>2</sup><sub>r</sub>) = 0.21) and that there were 7 SNPs in the <italic>NPPA</italic>/<italic>NPPB</italic> region associated with NT-proBNP level. The minor alleles of rs632793 and rs41300100 were independently associated with higher NT-proBNP level. Additionally, NT-proBNP was positively associated with age and male sex, but negatively associated with BMI, blood pressure, AF, and MI. The minor allele of rs632793 was inversely associated with SBP, DBP, and a history of AF. The significant association of SNPs with blood pressures was independent of NT-proBNP level, which may suggest that not all of the genetic association was explained by NT-proBNP level, though longitudinal analyses would be needed to determine this for certain. Lastly, results with prevalent CVDs also showed an interaction with age group (i.e., generation); thereby, highlighting the age-related differences in BNP function.</p>
              <p>These results are consistent with previous findings that NT-proBNP is heritable (previous evidence H<sup>2</sup><sub>r</sub> = 0.34) [<xref rid="pone.0248726.ref013" ref-type="bibr">13</xref>] and that common SNPs in the <italic>NPPA</italic>/<italic>NPPB</italic> region are associated with circulating NT-proBNP level [<xref rid="pone.0248726.ref015" ref-type="bibr">15</xref>, <xref rid="pone.0248726.ref016" ref-type="bibr">16</xref>, <xref rid="pone.0248726.ref023" ref-type="bibr">23</xref>, <xref rid="pone.0248726.ref024" ref-type="bibr">24</xref>]. Our results are also similar to previous studies showing that NT-proBNP is positively associated with age [<xref rid="pone.0248726.ref025" ref-type="bibr">25</xref>] and inversely associated with BMI [<xref rid="pone.0248726.ref026" ref-type="bibr">26</xref>]. We identified rs632793 as the most significant and consistent genetic variant associated with NT-proBNP level in the total LLFS, as well as, in the proband generation alone. This is in line with previous studies [<xref rid="pone.0248726.ref014" ref-type="bibr">14</xref>, <xref rid="pone.0248726.ref016" ref-type="bibr">16</xref>, <xref rid="pone.0248726.ref027" ref-type="bibr">27</xref>, <xref rid="pone.0248726.ref028" ref-type="bibr">28</xref>], although, some other studies focused specifically and solely on rs198389 [<xref rid="pone.0248726.ref015" ref-type="bibr">15</xref>, <xref rid="pone.0248726.ref016" ref-type="bibr">16</xref>, <xref rid="pone.0248726.ref024" ref-type="bibr">24</xref>, <xref rid="pone.0248726.ref029" ref-type="bibr">29</xref>–<xref rid="pone.0248726.ref031" ref-type="bibr">31</xref>]. These two variants are in strong LD in our study (<xref ref-type="fig" rid="pone.0248726.g001">Fig 1</xref>) and; thus, likely represent the same underlying genetic signal.</p>
              <p>The somewhat counterintuitive association between SNPs in this region being associated with higher circulating NT-proBNP levels, but lower risk of cardiovascular conditions and risk factors even though higher NT-proBNP is associated with increased CVD risk, is consistent with previous reports [<xref rid="pone.0248726.ref014" ref-type="bibr">14</xref>, <xref rid="pone.0248726.ref016" ref-type="bibr">16</xref>, <xref rid="pone.0248726.ref032" ref-type="bibr">32</xref>–<xref rid="pone.0248726.ref034" ref-type="bibr">34</xref>]. The physiologic function of BNP is to relieve the heart of excess stress by reducing vascoconstriction [<xref rid="pone.0248726.ref008" ref-type="bibr">8</xref>, <xref rid="pone.0248726.ref035" ref-type="bibr">35</xref>], so it plays a protective role in early life. But in the presence or progression of cardiac disease, the body is required to up-regulate the expression of BNP in order to attempt to relieve the symptoms of disease [<xref rid="pone.0248726.ref015" ref-type="bibr">15</xref>] and which is in line with associations we saw between NT-proBNP level and CVD risk factors in the current study (<xref ref-type="supplementary-material" rid="pone.0248726.s001">S1 Table</xref>). This is why greater circulating BNP is indicative of disease and can be used as a clinical marker of HF diagnosis or progression. Interestingly, our interaction analyses showed that the genetic associations did not significantly differ by generation (i.e. aging) for NT-proBNP level, but did for blood pressure and hypertension. This also supports the hypothesis that the counterintuitive direction of effect is not driven by genetic effects, but rather by the body’s regulation of NT-proBNP levels in relation to progression of cardiovascular disease.</p>
              <p>The goal of the current study was to replicate and extend findings on BNP genetics and CVD that exist in the literature. However, it is unique to previous reports in that our families largely consist of exceptionally healthy, older adults with a low burden of CVD for their age compared to previous studies in high-risk groups. In the LLFS, we found that rs632793 which was associated with greater NT-proBNP level, was also associated with lower prevalence of cardiovascular conditions and risk factors. This relationship demonstrates the physiologic protective role of BNP across age groups and even in generally healthy adults, which suggests the relationships are not driven by a predisposition to a high risk of CVD. This idea is even more clear from the sensitivity analyses in individuals with normal NT-proBNP levels, which showed similar results to the whole LLFS cohort. This observation warrants further study of the clinical utility for CVD risk prediction of NT-proBNP in low-risk populations.</p>
              <p>The results of the current study identified SNPs that have previously been reported to be associated with NT-proBNP and/or CVD: primarily rs632793 (in LD with rs198389), but also rs41300100 and rs17376426. While the function of rs632793 is not known, it is located in the 5’ flanking promoter region and is predicted to be associated with transcription regulation [<xref rid="pone.0248726.ref036" ref-type="bibr">36</xref>]. Also, rs198389 (in LD with rs632793) is located in an upstream regulatory region of <italic>NPPB</italic> and the minor (G) allele has been shown to be associated with 1.8-fold higher <italic>NPPB</italic> promoter activity [<xref rid="pone.0248726.ref032" ref-type="bibr">32</xref>]. rs198389 has been associated with higher NT-proBNP and BNP levels [<xref rid="pone.0248726.ref012" ref-type="bibr">12</xref>, <xref rid="pone.0248726.ref015" ref-type="bibr">15</xref>, <xref rid="pone.0248726.ref016" ref-type="bibr">16</xref>, <xref rid="pone.0248726.ref023" ref-type="bibr">23</xref>, <xref rid="pone.0248726.ref024" ref-type="bibr">24</xref>, <xref rid="pone.0248726.ref032" ref-type="bibr">32</xref>–<xref rid="pone.0248726.ref034" ref-type="bibr">34</xref>, <xref rid="pone.0248726.ref037" ref-type="bibr">37</xref>], lower blood pressure and hypertension [<xref rid="pone.0248726.ref015" ref-type="bibr">15</xref>] and a reduced rate of cardiovascular readmission [<xref rid="pone.0248726.ref016" ref-type="bibr">16</xref>].</p>
              <p>In addition to rs632793, rs41300100 was associated with NT-proBNP level in all LLFS and hypertension in the proband generation, and rs17376426 was associated with NT-proBNP level independent of rs632793 in the offspring generation. rs41300100 is located in the 5 prime UTR of <italic>NPPA</italic>, and is predicted to lie in an enhancer region [<xref rid="pone.0248726.ref038" ref-type="bibr">38</xref>]. However, this particular SNP is not in LD with any other SNP in the region in the LLFS (<xref ref-type="fig" rid="pone.0248726.g001">Fig 1</xref>) and has not been reported to be associated with any traits to date. rs17376426 is located at 2KB upstream transcript variant and is predicted as a regulatory variant [<xref rid="pone.0248726.ref039" ref-type="bibr">39</xref>]. Therefore, the potential functional impact of rs41300100 and rs17376426 on NT-proBNP levels and/or function is unknown, and may warrant further investigation.</p>
              <p>This study has several strengths. First, the LLFS provided a wide age range of adults to test the genetic association of BNP and is the first study to conduct these analyses in exceptionally long-lived individuals at low-risk for CVD. While the exceptional longevity and healthier than age-matched indivudals of the LLFS may make it seem like it is not generalizable, there is still substantial chronic disease prevalence and a wide variation in all measures of health within the cohort [<xref rid="pone.0248726.ref018" ref-type="bibr">18</xref>]. Additionally, the family study design of LLFS allowed us to calculate the heritability of NT-proBNP and is only the second study to do so. There was also a reasonably large sample size (N = 4,331) for a candidate gene approach and we used the most reliable assay for NT-proBNP measurement. We also assessed our primary results using both a nominal (P≤0.05) and Bonferroni-corrected P-value threshold given our strong <italic>a priori</italic> hypotheses and limited scope of work. Lastly, we looked at multiple SNPs across the <italic>NPPA</italic>/<italic>NPPB</italic> region instead of only a single candidate SNP, as many previous reports of rs198389 have done [<xref rid="pone.0248726.ref015" ref-type="bibr">15</xref>, <xref rid="pone.0248726.ref023" ref-type="bibr">23</xref>, <xref rid="pone.0248726.ref024" ref-type="bibr">24</xref>, <xref rid="pone.0248726.ref033" ref-type="bibr">33</xref>, <xref rid="pone.0248726.ref040" ref-type="bibr">40</xref>, <xref rid="pone.0248726.ref041" ref-type="bibr">41</xref>]. This approach allowed for the identification of a number of SNPs in addition to rs198389 with significant associations to either NT-proBNP or CVD, that would have otherwise been missed.</p>
              <p>However, there are a number of additional considerations. We do not yet have longitudinal data on NT-proBNP or incident cardiovascular disease risk in the LLFS; however, as the study continues follow-up, we will be able to assess these in the future. As age is a strong, non-linear determinant of NT-proBNP level, the inclusion of a wide-range of ages may have attenuated our associations between genetic variants and NT-proBNP given the variation in risk prediction by CVD status. However, our sensitivity analyses in individuals with normal NT-proBNP levels attempted to minimize the influence of prevalent cardiac disease. Besides, we limited our study to SNPs in the <italic>NPPA</italic>/<italic>NPPB</italic> region on chromosome 1. We did this in order to look at the association of genetic variation around BNP with circulating BNP levels and only looked at common SNPs in order to minimize the number of tests. However, SNPs in other regions, such as rs11105306 located on chromosome 12 and rs13107352 located on chromosome 4, have also been shown to be associated with the circulating NT-proBNP levels [<xref rid="pone.0248726.ref030" ref-type="bibr">30</xref>], which we did not assess in the current study. In addition, there are a number of factors that were not included in our analyses as they were considered to potentially be a part of the causal pathway between BNP and CVD, including BMI, smoking, lipids, and diabetes. However, it is likely that these factors are involved in the reported relationships. Lastly, while we did not include a replication cohort, we started with an <italic>a priori</italic> hypothesis to do a candidate gene association study and our results were in-line with previous reports; thus, our study serves as replication to this previous work.</p>
              <p>We found that NT-proBNP level is significantly heritable in a cohort of families with exceptional aging: the LLFS. We also identified rs632793, rs41300100, and rs17376426 to be independently associated with NT-proBNP levels and related prevalent CVD conditions and risk factors. We showed that alleles associated with greater NT-proBNP were also associated with a lower prevalence of CVD conditions and risk factors, even though high NT-proBNP levels are used clinically to indicate heart failure. This seemingly counterintuitive result is consistent with previous reports and highlights the complex relationship and negative feedback loop of the BNP protein and cardiovascular conditions. As such, future research may benefit from taking into consideration genetic determinants when evaluating clinical use of BNP in the aging population.</p>
            </sec>
            <sec sec-type="supplementary-material" id="sec018">
              <title>Supporting information</title>
              <supplementary-material content-type="local-data" id="pone.0248726.s001">
                <label>S1 Table</label>
                <caption>
                  <title>Associations between NT-proBNP level and CVD measures.</title>
                  <p>(DOCX)</p>
                </caption>
                <media xlink:href="pone.0248726.s001.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="pone.0248726.s002">
                <label>S2 Table</label>
                <caption>
                  <title>Association between SNPs and NT-proBNP level in individuals with normal NP-proBNP level.</title>
                  <p>(DOCX)</p>
                </caption>
                <media xlink:href="pone.0248726.s002.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="pone.0248726.s003">
                <label>S3 Table</label>
                <caption>
                  <title>Association between significant SNPs and CVD measures in individuals with normal NP-proBNP level.</title>
                  <p>(DOCX)</p>
                </caption>
                <media xlink:href="pone.0248726.s003.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="pone.0248726.s004">
                <label>S4 Table</label>
                <caption>
                  <title>Association between significant SNPs and CVD measures in individuals with normal NP-proBNP level further adjusted for NT-proBNP level.</title>
                  <p>(DOCX)</p>
                </caption>
                <media xlink:href="pone.0248726.s004.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="pone.0248726.s005">
                <label>S5 Table</label>
                <caption>
                  <title>Association between significant SNPs and CVD measures further adjusted for NT-proBNP level.</title>
                  <p>(DOCX)</p>
                </caption>
                <media xlink:href="pone.0248726.s005.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="pone.0248726.s006">
                <label>S6 Table</label>
                <caption>
                  <title>Effect of the interaction between significant SNP and LLFS generation on CVD measures.</title>
                  <p>(DOCX)</p>
                </caption>
                <media xlink:href="pone.0248726.s006.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="pone.0248726.s007">
                <label>S7 Table</label>
                <caption>
                  <title>Basic characteristics of the LLFS by study center country.</title>
                  <p>(DOCX)</p>
                </caption>
                <media xlink:href="pone.0248726.s007.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="pone.0248726.s008">
                <label>S8 Table</label>
                <caption>
                  <title>Association of significant BNP variants with CVD measures stratified by study center country.</title>
                  <p>(DOCX)</p>
                </caption>
                <media xlink:href="pone.0248726.s008.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="pone.0248726.s009">
                <label>S1 File</label>
                <caption>
                  <title>Supporting information file containing all study questionnaires.</title>
                  <p>(PDF)</p>
                </caption>
                <media xlink:href="pone.0248726.s009.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ref-list>
              <title>References</title>
              <ref id="pone.0248726.ref001">
                <label>1</label>
                <mixed-citation publication-type="journal"><name><surname>Roth</surname><given-names>GA</given-names></name>, <name><surname>Johnson</surname><given-names>C</given-names></name>, <name><surname>Abajobir</surname><given-names>A</given-names></name>, <name><surname>Abd-Allah</surname><given-names>F</given-names></name>, <name><surname>Abera</surname><given-names>SF</given-names></name>, <name><surname>Abyu</surname><given-names>G</given-names></name>, <etal>et al</etal>. <article-title>Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015</article-title>. <source>Journal of the American College of Cardiology</source>. <year>2017</year>;<volume>70</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>25</lpage>. Epub 2017/05/22. <pub-id pub-id-type="doi">10.1016/j.jacc.2017.04.052</pub-id>
<?supplied-pmid 28527533?><pub-id pub-id-type="pmid">28527533</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0248726.ref002">
                <label>2</label>
                <mixed-citation publication-type="journal"><name><surname>Writing Committee</surname><given-names>M</given-names></name>, <name><surname>Yancy</surname><given-names>CW</given-names></name>, <name><surname>Jessup</surname><given-names>M</given-names></name>, <name><surname>Bozkurt</surname><given-names>B</given-names></name>, <name><surname>Butler</surname><given-names>J</given-names></name>, <name><surname>Casey</surname><given-names>DE</given-names><suffix>Jr.</suffix></name>, <etal>et al</etal>. <article-title>2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines</article-title>. <source>Circulation</source>. <year>2013</year>;<volume>128</volume>(<issue>16</issue>):<fpage>e240</fpage>–<lpage>327</lpage>. Epub 2013/06/07. <pub-id pub-id-type="doi">10.1161/CIR.0b013e31829e8776</pub-id> .<?supplied-pmid 23741058?><pub-id pub-id-type="pmid">23741058</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0248726.ref003">
                <label>3</label>
                <mixed-citation publication-type="journal"><name><surname>Bower</surname><given-names>JK</given-names></name>, <name><surname>Lazo</surname><given-names>M</given-names></name>, <name><surname>Matsushita</surname><given-names>K</given-names></name>, <name><surname>Rubin</surname><given-names>J</given-names></name>, <name><surname>Hoogeveen</surname><given-names>RC</given-names></name>, <name><surname>Ballantyne</surname><given-names>CM</given-names></name>, <etal>et al</etal>. <article-title>N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) and Risk of Hypertension in the Atherosclerosis Risk in Communities (ARIC) Study</article-title>. <source>American journal of hypertension</source>. <year>2015</year>;<volume>28</volume>(<issue>10</issue>):<fpage>1262</fpage>–<lpage>6</lpage>. Epub 2015/03/19. <pub-id pub-id-type="doi">10.1093/ajh/hpv026</pub-id>
<?supplied-pmid 25783741?><pub-id pub-id-type="pmid">25783741</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0248726.ref004">
                <label>4</label>
                <mixed-citation publication-type="journal"><name><surname>Khan</surname><given-names>AM</given-names></name>, <name><surname>Cheng</surname><given-names>S</given-names></name>, <name><surname>Magnusson</surname><given-names>M</given-names></name>, <name><surname>Larson</surname><given-names>MG</given-names></name>, <name><surname>Newton-Cheh</surname><given-names>C</given-names></name>, <name><surname>McCabe</surname><given-names>EL</given-names></name>, <etal>et al</etal>. <article-title>Cardiac natriuretic peptides, obesity, and insulin resistance: evidence from two community-based studies</article-title>. <source>The Journal of clinical endocrinology and metabolism</source>. <year>2011</year>;<volume>96</volume>(<issue>10</issue>):<fpage>3242</fpage>–<lpage>9</lpage>. Epub 2011/08/19. <pub-id pub-id-type="doi">10.1210/jc.2011-1182</pub-id>
<?supplied-pmid 21849523?><pub-id pub-id-type="pmid">21849523</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0248726.ref005">
                <label>5</label>
                <mixed-citation publication-type="journal"><name><surname>Sanchez</surname><given-names>OA</given-names></name>, <name><surname>Duprez</surname><given-names>DA</given-names></name>, <name><surname>Bahrami</surname><given-names>H</given-names></name>, <name><surname>Peralta</surname><given-names>CA</given-names></name>, <name><surname>Daniels</surname><given-names>LB</given-names></name>, <name><surname>Lima</surname><given-names>JA</given-names></name>, <etal>et al</etal>. <article-title>Changes in N-terminal pro-B-type natriuretic peptide and incidence of diabetes: The Multi-Ethnic Study of Atherosclerosis (MESA)</article-title>. <source>Diabetes Metab</source>. <year>2015</year>;<volume>41</volume>(<issue>5</issue>):<fpage>378</fpage>–<lpage>86</lpage>. Epub 2015/06/07. <pub-id pub-id-type="doi">10.1016/j.diabet.2015.04.005</pub-id>
<?supplied-pmid 26047677?><pub-id pub-id-type="pmid">26047677</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0248726.ref006">
                <label>6</label>
                <mixed-citation publication-type="journal"><name><surname>Goetze</surname><given-names>JP</given-names></name>. <article-title>B-type natriuretic peptide: from posttranslational processing to clinical measurement</article-title>. <source>Clin Chem</source>. <year>2012</year>;<volume>58</volume>(<issue>1</issue>):<fpage>83</fpage>–<lpage>91</lpage>. Epub 2011/12/01. <pub-id pub-id-type="doi">10.1373/clinchem.2011.165696</pub-id> .<?supplied-pmid 22126935?><pub-id pub-id-type="pmid">22126935</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0248726.ref007">
                <label>7</label>
                <mixed-citation publication-type="journal"><name><surname>Clerico</surname><given-names>A</given-names></name>, <name><surname>Vittorini</surname><given-names>S</given-names></name>, <name><surname>Passino</surname><given-names>C</given-names></name>. <article-title>Measurement of the pro-hormone of brain type natriuretic peptide (proBNP): methodological considerations and pathophysiological relevance</article-title>. <source>Clin Chem Lab Med</source>. <year>2011</year>;<volume>49</volume>(<issue>12</issue>):<fpage>1949</fpage>–<lpage>54</lpage>. Epub 2011/08/27. <pub-id pub-id-type="doi">10.1515/CCLM.2011.686</pub-id> .<?supplied-pmid 21867450?><pub-id pub-id-type="pmid">21867450</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0248726.ref008">
                <label>8</label>
                <mixed-citation publication-type="journal"><name><surname>Richards</surname><given-names>AM</given-names></name>. <article-title>N-Terminal B-type Natriuretic Peptide in Heart Failure</article-title>. <source>Heart Fail Clin</source>. <year>2018</year>;<volume>14</volume>(<issue>1</issue>):<fpage>27</fpage>–<lpage>39</lpage>. Epub 2017/11/21. <pub-id pub-id-type="doi">10.1016/j.hfc.2017.08.004</pub-id> .<?supplied-pmid 29153198?><pub-id pub-id-type="pmid">29153198</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0248726.ref009">
                <label>9</label>
                <mixed-citation publication-type="journal"><name><surname>Ponikowski</surname><given-names>P</given-names></name>, <name><surname>Voors</surname><given-names>AA</given-names></name>, <name><surname>Anker</surname><given-names>SD</given-names></name>, <name><surname>Bueno</surname><given-names>H</given-names></name>, <name><surname>Cleland</surname><given-names>JGF</given-names></name>, <name><surname>Coats</surname><given-names>AJS</given-names></name>, <etal>et al</etal>. <article-title>2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC</article-title>. <source>Eur Heart J</source>. <year>2016</year>;<volume>37</volume>(<issue>27</issue>):<fpage>2129</fpage>–<lpage>200</lpage>. Epub 2016/05/22. <pub-id pub-id-type="doi">10.1093/eurheartj/ehw128</pub-id> .<?supplied-pmid 27206819?><pub-id pub-id-type="pmid">27206819</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0248726.ref010">
                <label>10</label>
                <mixed-citation publication-type="journal"><name><surname>Fuster</surname><given-names>V</given-names></name>, <name><surname>Ryden</surname><given-names>LE</given-names></name>, <name><surname>Cannom</surname><given-names>DS</given-names></name>, <name><surname>Crijns</surname><given-names>HJ</given-names></name>, <name><surname>Curtis</surname><given-names>AB</given-names></name>, <name><surname>Ellenbogen</surname><given-names>KA</given-names></name>, <etal>et al</etal>. <article-title>ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society</article-title>. <source>Circulation</source>. <year>2006</year>;<volume>114</volume>(<issue>7</issue>):<fpage>e257</fpage>–<lpage>354</lpage>. Epub 2006/08/16. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.106.177292</pub-id> .<?supplied-pmid 16908781?><pub-id pub-id-type="pmid">16908781</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0248726.ref011">
                <label>11</label>
                <mixed-citation publication-type="journal"><name><surname>McCullough</surname><given-names>PA</given-names></name>, <name><surname>Kluger</surname><given-names>AY</given-names></name>. <article-title>Interpreting the Wide Range of NT-proBNP Concentrations in Clinical Decision Making</article-title>. <source>Journal of the American College of Cardiology</source>. <year>2018</year>;<volume>71</volume>(<issue>11</issue>):<fpage>1201</fpage>–<lpage>3</lpage>. Epub 2018/03/17. <pub-id pub-id-type="doi">10.1016/j.jacc.2018.01.056</pub-id> .<?supplied-pmid 29544602?><pub-id pub-id-type="pmid">29544602</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0248726.ref012">
                <label>12</label>
                <mixed-citation publication-type="journal"><name><surname>Lanfear</surname><given-names>DE</given-names></name>, <name><surname>Stolker</surname><given-names>JM</given-names></name>, <name><surname>Marsh</surname><given-names>S</given-names></name>, <name><surname>Rich</surname><given-names>MW</given-names></name>, <name><surname>McLeod</surname><given-names>HL</given-names></name>. <article-title>Genetic variation in the B-type natiuretic peptide pathway affects BNP levels</article-title>. <source>Cardiovasc Drugs Ther</source>. <year>2007</year>;<volume>21</volume>(<issue>1</issue>):<fpage>55</fpage>–<lpage>62</lpage>. Epub 2007/03/07. <pub-id pub-id-type="doi">10.1007/s10557-007-6007-5</pub-id> .<?supplied-pmid 17340039?><pub-id pub-id-type="pmid">17340039</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0248726.ref013">
                <label>13</label>
                <mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>TJ</given-names></name>, <name><surname>Larson</surname><given-names>MG</given-names></name>, <name><surname>Levy</surname><given-names>D</given-names></name>, <name><surname>Benjamin</surname><given-names>EJ</given-names></name>, <name><surname>Corey</surname><given-names>D</given-names></name>, <name><surname>Leip</surname><given-names>EP</given-names></name>, <etal>et al</etal>. <article-title>Heritability and genetic linkage of plasma natriuretic peptide levels</article-title>. <source>Circulation</source>. <year>2003</year>;<volume>108</volume>(<issue>1</issue>):<fpage>13</fpage>–<lpage>6</lpage>. Epub 2003/06/25. <pub-id pub-id-type="doi">10.1161/01.CIR.0000081657.83724.A7</pub-id> .<?supplied-pmid 12821537?><pub-id pub-id-type="pmid">12821537</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0248726.ref014">
                <label>14</label>
                <mixed-citation publication-type="journal"><name><surname>Newton-Cheh</surname><given-names>C</given-names></name>, <name><surname>Larson</surname><given-names>MG</given-names></name>, <name><surname>Vasan</surname><given-names>RS</given-names></name>, <name><surname>Levy</surname><given-names>D</given-names></name>, <name><surname>Bloch</surname><given-names>KD</given-names></name>, <name><surname>Surti</surname><given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure</article-title>. <source>Nat Genet</source>. <year>2009</year>;<volume>41</volume>(<issue>3</issue>):<fpage>348</fpage>–<lpage>53</lpage>. Epub 2009/02/17. <pub-id pub-id-type="doi">10.1038/ng.328</pub-id>
<?supplied-pmid 19219041?><pub-id pub-id-type="pmid">19219041</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0248726.ref015">
                <label>15</label>
                <mixed-citation publication-type="journal"><name><surname>Seidelmann</surname><given-names>SB</given-names></name>, <name><surname>Vardeny</surname><given-names>O</given-names></name>, <name><surname>Claggett</surname><given-names>B</given-names></name>, <name><surname>Yu</surname><given-names>B</given-names></name>, <name><surname>Shah</surname><given-names>AM</given-names></name>, <name><surname>Ballantyne</surname><given-names>CM</given-names></name>, <etal>et al</etal>. <article-title>An NPPB Promoter Polymorphism Associated With Elevated N-Terminal pro-B-Type Natriuretic Peptide and Lower Blood Pressure, Hypertension, and Mortality</article-title>. <source>Journal of the American Heart Association</source>. <year>2017</year>;<volume>6</volume>(<issue>4</issue>). Epub 2017/03/28. <pub-id pub-id-type="doi">10.1161/jaha.116.005257</pub-id><?supplied-pmid 28341776?><pub-id pub-id-type="pmid">28341776</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0248726.ref016">
                <label>16</label>
                <mixed-citation publication-type="journal"><name><surname>Ellis</surname><given-names>KL</given-names></name>, <name><surname>Newton-Cheh</surname><given-names>C</given-names></name>, <name><surname>Wang</surname><given-names>TJ</given-names></name>, <name><surname>Frampton</surname><given-names>CM</given-names></name>, <name><surname>Doughty</surname><given-names>RN</given-names></name>, <name><surname>Whalley</surname><given-names>GA</given-names></name>, <etal>et al</etal>. <article-title>Association of genetic variation in the natriuretic peptide system with cardiovascular outcomes</article-title>. <source>Journal of molecular and cellular cardiology</source>. <year>2011</year>;<volume>50</volume>(<issue>4</issue>):<fpage>695</fpage>–<lpage>701</lpage>. Epub 2011/02/01. <pub-id pub-id-type="doi">10.1016/j.yjmcc.2011.01.010</pub-id> .<?supplied-pmid 21276798?><pub-id pub-id-type="pmid">21276798</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0248726.ref017">
                <label>17</label>
                <mixed-citation publication-type="journal"><name><surname>Kragelund</surname><given-names>C</given-names></name>, <name><surname>Grønning</surname><given-names>B</given-names></name>, <name><surname>Køber</surname><given-names>L</given-names></name>, <name><surname>Hildebrandt</surname><given-names>P</given-names></name>, <name><surname>Steffensen</surname><given-names>R</given-names></name>. <article-title>N-Terminal Pro–B-Type Natriuretic Peptide and Long-Term Mortality in Stable Coronary Heart Disease</article-title>. <source>New England Journal of Medicine</source>. <year>2005</year>;<volume>352</volume>(<issue>7</issue>). <pub-id pub-id-type="doi">10.1056/NEJMoa042330</pub-id><?supplied-pmid 15716560?><pub-id pub-id-type="pmid">15716560</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0248726.ref018">
                <label>18</label>
                <mixed-citation publication-type="journal"><name><surname>Newman</surname><given-names>AB</given-names></name>, <name><surname>Glynn</surname><given-names>NW</given-names></name>, <name><surname>Taylor</surname><given-names>CA</given-names></name>, <name><surname>Sebastiani</surname><given-names>P</given-names></name>, <name><surname>Perls</surname><given-names>TT</given-names></name>, <name><surname>Mayeux</surname><given-names>R</given-names></name>, <etal>et al</etal>. <article-title>Health and function of participants in the Long Life Family Study: A comparison with other cohorts</article-title>. <source>Aging (Albany NY)</source>. <year>2011</year>;<volume>3</volume>(<issue>1</issue>):<fpage>63</fpage>–<lpage>76</lpage>. Epub 2011/01/25. <pub-id pub-id-type="doi">10.18632/aging.100242</pub-id>
<?supplied-pmid 21258136?><pub-id pub-id-type="pmid">21258136</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0248726.ref019">
                <label>19</label>
                <mixed-citation publication-type="journal"><name><surname>Sebastiani</surname><given-names>P</given-names></name>, <name><surname>Hadley</surname><given-names>EC</given-names></name>, <name><surname>Province</surname><given-names>M</given-names></name>, <name><surname>Christensen</surname><given-names>K</given-names></name>, <name><surname>Rossi</surname><given-names>W</given-names></name>, <name><surname>Perls</surname><given-names>TT</given-names></name>, <etal>et al</etal>. <article-title>A family longevity selection score: ranking sibships by their longevity, size, and availability for study</article-title>. <source>American journal of epidemiology</source>. <year>2009</year>;<volume>170</volume>(<issue>12</issue>):<fpage>1555</fpage>–<lpage>62</lpage>. Epub 2009/11/17. <pub-id pub-id-type="doi">10.1093/aje/kwp309</pub-id>
<?supplied-pmid 19910380?><pub-id pub-id-type="pmid">19910380</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0248726.ref020">
                <label>20</label>
                <mixed-citation publication-type="journal"><name><surname>Man</surname><given-names>J</given-names></name>, <name><surname>Barnett</surname><given-names>P</given-names></name>, <name><surname>Christoffels</surname><given-names>VM</given-names></name>. <article-title>Structure and function of the Nppa-Nppb cluster locus during heart development and disease</article-title>. <source>Cell Mol Life Sci</source>. <year>2018</year>;<volume>75</volume>(<issue>8</issue>):<fpage>1435</fpage>–<lpage>44</lpage>. Epub 2018/01/06. <pub-id pub-id-type="doi">10.1007/s00018-017-2737-0</pub-id>
<?supplied-pmid 29302701?><pub-id pub-id-type="pmid">29302701</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0248726.ref021">
                <label>21</label>
                <mixed-citation publication-type="journal"><name><surname>Almasy</surname><given-names>L</given-names></name>, <name><surname>Blangero</surname><given-names>J</given-names></name>. <article-title>Multipoint quantitative-trait linkage analysis in general pedigrees</article-title>. <source>Am J Hum Genet</source>. <year>1998</year>;<volume>62</volume>(<issue>5</issue>):<fpage>1198</fpage>–<lpage>211</lpage>. Epub 1998/05/23. S0002-9297(07)61542-0 [pii] <pub-id pub-id-type="doi">10.1086/301844</pub-id> .<?supplied-pmid 9545414?><pub-id pub-id-type="pmid">9545414</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0248726.ref022">
                <label>22</label>
                <mixed-citation publication-type="journal"><name><surname>Gustafsson</surname><given-names>F</given-names></name>, <name><surname>Steensgaard-Hansen</surname><given-names>F</given-names></name>, <name><surname>Badskjaer</surname><given-names>J</given-names></name>, <name><surname>Poulsen</surname><given-names>AH</given-names></name>, <name><surname>Corell</surname><given-names>P</given-names></name>, <name><surname>Hildebrandt</surname><given-names>P</given-names></name>. <article-title>Diagnostic and prognostic performance of N-terminal ProBNP in primary care patients with suspected heart failure</article-title>. <source>Journal of cardiac failure</source>. <year>2005</year>;<volume>11</volume>(<issue>5 Suppl</issue>):<fpage>S15</fpage>–<lpage>20</lpage>. Epub 2005/06/11. <pub-id pub-id-type="doi">10.1016/j.cardfail.2005.04.022</pub-id> .<?supplied-pmid 15948095?><pub-id pub-id-type="pmid">15948095</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0248726.ref023">
                <label>23</label>
                <mixed-citation publication-type="journal"><name><surname>Costello-Boerrigter</surname><given-names>LC</given-names></name>, <name><surname>Boerrigter</surname><given-names>G</given-names></name>, <name><surname>Ameenuddin</surname><given-names>S</given-names></name>, <name><surname>Mahoney</surname><given-names>DW</given-names></name>, <name><surname>Slusser</surname><given-names>JP</given-names></name>, <name><surname>Heublein</surname><given-names>DM</given-names></name>, <etal>et al</etal>. <article-title>The effect of the brain-type natriuretic peptide single-nucleotide polymorphism rs198389 on test characteristics of common assays</article-title>. <source>Mayo Clin Proc</source>. <year>2011</year>;<volume>86</volume>(<issue>3</issue>):<fpage>210</fpage>–<lpage>8</lpage>. Epub 2011/03/03. <pub-id pub-id-type="doi">10.4065/mcp.2010.0708</pub-id>
<?supplied-pmid 21364112?><pub-id pub-id-type="pmid">21364112</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0248726.ref024">
                <label>24</label>
                <mixed-citation publication-type="journal"><name><surname>Lajer</surname><given-names>M</given-names></name>, <name><surname>Tarnow</surname><given-names>L</given-names></name>, <name><surname>Jorsal</surname><given-names>A</given-names></name>, <name><surname>Parving</surname><given-names>HH</given-names></name>. <article-title>Polymorphisms in the B-type natriuretic peptide (BNP) gene are associated with NT-proBNP levels but not with diabetic nephropathy or mortality in type 1 diabetic patients</article-title>. <source>Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association—European Renal Association</source>. <year>2007</year>;<volume>22</volume>(<issue>11</issue>):<fpage>3235</fpage>–<lpage>9</lpage>. Epub 2007/06/15. <pub-id pub-id-type="doi">10.1093/ndt/gfm360</pub-id> .<?supplied-pmid 17567649?><pub-id pub-id-type="pmid">17567649</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0248726.ref025">
                <label>25</label>
                <mixed-citation publication-type="journal"><name><surname>Redfield</surname><given-names>MM</given-names></name>, <name><surname>Rodeheffer</surname><given-names>RJ</given-names></name>, <name><surname>Jacobsen</surname><given-names>SJ</given-names></name>, <name><surname>Mahoney</surname><given-names>DW</given-names></name>, <name><surname>Bailey</surname><given-names>KR</given-names></name>, <name><surname>Burnett</surname><given-names>JC</given-names><suffix>Jr.</suffix></name>, <article-title>Plasma brain natriuretic peptide concentration: impact of age and gender</article-title>. <source>Journal of the American College of Cardiology</source>. <year>2002</year>;<volume>40</volume>(<issue>5</issue>):<fpage>976</fpage>–<lpage>82</lpage>. Epub 2002/09/13. <pub-id pub-id-type="doi">10.1016/s0735-1097(02)02059-4</pub-id> .<?supplied-pmid 12225726?><pub-id pub-id-type="pmid">12225726</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0248726.ref026">
                <label>26</label>
                <mixed-citation publication-type="journal"><name><surname>Park</surname><given-names>SJ</given-names></name>, <name><surname>Cho</surname><given-names>KI</given-names></name>, <name><surname>Jung</surname><given-names>SJ</given-names></name>, <name><surname>Choi</surname><given-names>SW</given-names></name>, <name><surname>Choi</surname><given-names>JW</given-names></name>, <name><surname>Lee</surname><given-names>DW</given-names></name>, <etal>et al</etal>. <article-title>N-terminal pro-B-type natriuretic Peptide in overweight and obese patients with and without diabetes: an analysis based on body mass index and left ventricular geometry</article-title>. <source>Korean Circ J</source>. <year>2009</year>;<volume>39</volume>(<issue>12</issue>):<fpage>538</fpage>–<lpage>44</lpage>. Epub 2010/01/06. <pub-id pub-id-type="doi">10.4070/kcj.2009.39.12.538</pub-id>
<?supplied-pmid 20049140?><pub-id pub-id-type="pmid">20049140</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0248726.ref027">
                <label>27</label>
                <mixed-citation publication-type="journal"><name><surname>Del Greco</surname><given-names>MF</given-names></name>, <name><surname>Pattaro</surname><given-names>C</given-names></name>, <name><surname>Luchner</surname><given-names>A</given-names></name>, <name><surname>Pichler</surname><given-names>I</given-names></name>, <name><surname>Winkler</surname><given-names>T</given-names></name>, <name><surname>Hicks</surname><given-names>AA</given-names></name>, <etal>et al</etal>. <article-title>Genome-wide association analysis and fine mapping of NT-proBNP level provide novel insight into the role of the MTHFR-CLCN6-NPPA-NPPB gene cluster</article-title>. <source>Hum Mol Genet</source>. <year>2011</year>;<volume>20</volume>(<issue>8</issue>):<fpage>1660</fpage>–<lpage>71</lpage>. Epub 2011/01/29. <pub-id pub-id-type="doi">10.1093/hmg/ddr035</pub-id>
<?supplied-pmid 21273288?><pub-id pub-id-type="pmid">21273288</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0248726.ref028">
                <label>28</label>
                <mixed-citation publication-type="journal"><name><surname>Wu</surname><given-names>Z</given-names></name>, <name><surname>Xu</surname><given-names>M</given-names></name>, <name><surname>Sheng</surname><given-names>H</given-names></name>, <name><surname>Lou</surname><given-names>Y</given-names></name>, <name><surname>Su</surname><given-names>X</given-names></name>, <name><surname>Chen</surname><given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>Association of natriuretic peptide polymorphisms with left ventricular dysfunction in southern Han Chinese coronary artery disease patients</article-title>. <source>Int J Clin Exp Pathol</source>. <year>2014</year>;<volume>7</volume>(<issue>10</issue>):<fpage>7148</fpage>–<lpage>57</lpage>. Epub 2014/11/18. <?supplied-pmid 25400811?><pub-id pub-id-type="pmid">25400811</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0248726.ref029">
                <label>29</label>
                <mixed-citation publication-type="journal"><name><surname>Jin</surname><given-names>G</given-names></name>, <name><surname>Chen</surname><given-names>Z</given-names></name>, <name><surname>Zhang</surname><given-names>J</given-names></name>, <name><surname>Song</surname><given-names>J</given-names></name>, <name><surname>Shi</surname><given-names>J</given-names></name>, <name><surname>Zhou</surname><given-names>B</given-names></name>. <article-title>Association of brain natriuretic peptide gene polymorphisms with chronic obstructive pulmonary disease complicated with pulmonary hypertension and its mechanism</article-title>. <source>Biosci Rep</source>. <year>2018</year>;<volume>38</volume>(<issue>5</issue>). Epub 2018/09/16. <pub-id pub-id-type="doi">10.1042/BSR20180905</pub-id><?supplied-pmid 30217946?><pub-id pub-id-type="pmid">30217946</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0248726.ref030">
                <label>30</label>
                <mixed-citation publication-type="journal"><name><surname>Johansson</surname><given-names>A</given-names></name>, <name><surname>Eriksson</surname><given-names>N</given-names></name>, <name><surname>Lindholm</surname><given-names>D</given-names></name>, <name><surname>Varenhorst</surname><given-names>C</given-names></name>, <name><surname>James</surname><given-names>S</given-names></name>, <name><surname>Syvanen</surname><given-names>AC</given-names></name>, <etal>et al</etal>. <article-title>Genome-wide association and Mendelian randomization study of NT-proBNP in patients with acute coronary syndrome</article-title>. <source>Hum Mol Genet</source>. <year>2016</year>;<volume>25</volume>(<issue>7</issue>):<fpage>1447</fpage>–<lpage>56</lpage>. Epub 2016/02/26. <pub-id pub-id-type="doi">10.1093/hmg/ddw012</pub-id> .<?supplied-pmid 26908625?><pub-id pub-id-type="pmid">26908625</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0248726.ref031">
                <label>31</label>
                <mixed-citation publication-type="journal"><name><surname>Poręba</surname><given-names>R</given-names></name>, <name><surname>Początek</surname><given-names>K</given-names></name>, <name><surname>Gać</surname><given-names>P</given-names></name>, <name><surname>Poręba</surname><given-names>M</given-names></name>, <name><surname>Gonerska</surname><given-names>M</given-names></name>, <name><surname>Jonkisz</surname><given-names>A</given-names></name>, <etal>et al</etal>. <article-title>SNP rs198389 (T‑381 C) polymorphism in the B‑type natriuretic peptide gene promoter in patients with atherosclerotic renovascular hypertension</article-title>. <source>Polish Archives of Internal Medicine</source>. <year>2009</year>;<volume>119</volume>(<issue>4</issue>):<fpage>219</fpage>–<lpage>24</lpage>. <pub-id pub-id-type="doi">10.20452/pamw.658</pub-id>
<?supplied-pmid 19413180?><pub-id pub-id-type="pmid">19413180</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0248726.ref032">
                <label>32</label>
                <mixed-citation publication-type="journal"><name><surname>Meirhaeghe</surname><given-names>A</given-names></name>, <name><surname>Sandhu</surname><given-names>MS</given-names></name>, <name><surname>McCarthy</surname><given-names>MI</given-names></name>, <name><surname>de Groote</surname><given-names>P</given-names></name>, <name><surname>Cottel</surname><given-names>D</given-names></name>, <name><surname>Arveiler</surname><given-names>D</given-names></name>, <etal>et al</etal>. <article-title>Association between the T-381C polymorphism of the brain natriuretic peptide gene and risk of type 2 diabetes in human populations</article-title>. <source>Hum Mol Genet</source>. <year>2007</year>;<volume>16</volume>(<issue>11</issue>):<fpage>1343</fpage>–<lpage>50</lpage>. Epub 2007/04/07. <pub-id pub-id-type="doi">10.1093/hmg/ddm084</pub-id> .<?supplied-pmid 17412758?><pub-id pub-id-type="pmid">17412758</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0248726.ref033">
                <label>33</label>
                <mixed-citation publication-type="journal"><name><surname>Pfister</surname><given-names>R</given-names></name>, <name><surname>Sharp</surname><given-names>S</given-names></name>, <name><surname>Luben</surname><given-names>R</given-names></name>, <name><surname>Welsh</surname><given-names>P</given-names></name>, <name><surname>Barroso</surname><given-names>I</given-names></name>, <name><surname>Salomaa</surname><given-names>V</given-names></name>, <etal>et al</etal>. <article-title>Mendelian randomization study of B-type natriuretic peptide and type 2 diabetes: evidence of causal association from population studies</article-title>. <source>PLoS medicine</source>. <year>2011</year>;<volume>8</volume>(<issue>10</issue>):<fpage>e1001112</fpage>. Epub 2011/11/01. <pub-id pub-id-type="doi">10.1371/journal.pmed.1001112</pub-id><?supplied-pmid 22039354?><pub-id pub-id-type="pmid">22039354</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0248726.ref034">
                <label>34</label>
                <mixed-citation publication-type="journal"><name><surname>Musani</surname><given-names>SK</given-names></name>, <name><surname>Fox</surname><given-names>ER</given-names></name>, <name><surname>Kraja</surname><given-names>A</given-names></name>, <name><surname>Bidulescu</surname><given-names>A</given-names></name>, <name><surname>Lieb</surname><given-names>W</given-names></name>, <name><surname>Lin</surname><given-names>H</given-names></name>, <etal>et al</etal>. <article-title>Genome-wide association analysis of plasma B-type natriuretic peptide in blacks: the Jackson Heart Study</article-title>. <source>Circulation Cardiovascular genetics</source>. <year>2015</year>;<volume>8</volume>(<issue>1</issue>):<fpage>122</fpage>–<lpage>30</lpage>. Epub 2015/01/07. <pub-id pub-id-type="doi">10.1161/CIRCGENETICS.114.000900</pub-id>
<?supplied-pmid 25561047?><pub-id pub-id-type="pmid">25561047</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0248726.ref035">
                <label>35</label>
                <mixed-citation publication-type="journal"><name><surname>Luchner</surname><given-names>A</given-names></name>, <name><surname>Stevens</surname><given-names>TL</given-names></name>, <name><surname>Borgeson</surname><given-names>DD</given-names></name>, <name><surname>Redfield</surname><given-names>M</given-names></name>, <name><surname>Wei</surname><given-names>CM</given-names></name>, <name><surname>Porter</surname><given-names>JG</given-names></name>, <etal>et al</etal>. <article-title>Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure</article-title>. <source>Am J Physiol</source>. <year>1998</year>;<volume>274</volume>(<issue>5</issue>):<fpage>H1684</fpage>–<lpage>9</lpage>. Epub 1998/06/05. <pub-id pub-id-type="doi">10.1152/ajpheart.1998.274.5.H1684</pub-id> .<?supplied-pmid 9612380?><pub-id pub-id-type="pmid">9612380</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0248726.ref036">
                <label>36</label>
                <mixed-citation publication-type="journal"><name><surname>Budoff</surname><given-names>MJ</given-names></name>, <name><surname>Nasir</surname><given-names>K</given-names></name>, <name><surname>Mao</surname><given-names>S</given-names></name>, <name><surname>Tseng</surname><given-names>PH</given-names></name>, <name><surname>Chau</surname><given-names>A</given-names></name>, <name><surname>Liu</surname><given-names>ST</given-names></name>, <etal>et al</etal>. <article-title>Ethnic differences of the presence and severity of coronary atherosclerosis</article-title>. <source>Atherosclerosis</source>. <year>2006</year>;<volume>187</volume>(<issue>2</issue>):<fpage>343</fpage>–<lpage>50</lpage>. Epub 2005/10/26. S0021-9150(05)00600-3 [pii] <pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2005.09.013</pub-id> .<?supplied-pmid 16246347?><pub-id pub-id-type="pmid">16246347</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0248726.ref037">
                <label>37</label>
                <mixed-citation publication-type="journal"><name><surname>Takeishi</surname><given-names>Y</given-names></name>, <name><surname>Toriyama</surname><given-names>S</given-names></name>, <name><surname>Takabatake</surname><given-names>N</given-names></name>, <name><surname>Shibata</surname><given-names>Y</given-names></name>, <name><surname>Konta</surname><given-names>T</given-names></name>, <name><surname>Emi</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Linkage disequilibrium analyses of natriuretic peptide precursor B locus reveal risk haplotype conferring high plasma BNP levels</article-title>. <source>Biochemical and biophysical research communications</source>. <year>2007</year>;<volume>362</volume>(<issue>2</issue>):<fpage>480</fpage>–<lpage>4</lpage>. Epub 2007/08/28. <pub-id pub-id-type="doi">10.1016/j.bbrc.2007.08.028</pub-id> .<?supplied-pmid 17719005?><pub-id pub-id-type="pmid">17719005</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0248726.ref038">
                <label>38</label>
                <mixed-citation publication-type="journal"><name><surname>Register</surname><given-names>TC</given-names></name>, <name><surname>Hruska</surname><given-names>KA</given-names></name>, <name><surname>Divers</surname><given-names>J</given-names></name>, <name><surname>Bowden</surname><given-names>DW</given-names></name>, <name><surname>Palmer</surname><given-names>ND</given-names></name>, <name><surname>Carr</surname><given-names>JJ</given-names></name>, <etal>et al</etal>. <article-title>Plasma Dickkopf1 (DKK1) Concentrations Negatively Associate with Atherosclerotic Calcified Plaque in African-Americans with Type 2 Diabetes</article-title>. <source>The Journal of clinical endocrinology and metabolism</source>. <year>2013</year>. Epub 2012/11/06. jc.2012-3038 [pii] <pub-id pub-id-type="doi">10.1210/jc.2012-3038</pub-id> .<?supplied-pmid 23125289?><pub-id pub-id-type="pmid">23125289</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0248726.ref039">
                <label>39</label>
                <mixed-citation publication-type="journal"><name><surname>Claes</surname><given-names>KJ</given-names></name>, <name><surname>Viaene</surname><given-names>L</given-names></name>, <name><surname>Heye</surname><given-names>S</given-names></name>, <name><surname>Meijers</surname><given-names>B</given-names></name>, <name><surname>d’Haese</surname><given-names>P</given-names></name>, <name><surname>Evenepoel</surname><given-names>P</given-names></name>. <article-title>Sclerostin: Another vascular calcification inhibitor?</article-title><source>The Journal of clinical endocrinology and metabolism</source>. <year>2013</year>;<volume>98</volume>(<issue>8</issue>):<fpage>3221</fpage>–<lpage>8</lpage>. Epub 2013/06/22. <pub-id pub-id-type="doi">10.1210/jc.2013-1521</pub-id> .<?supplied-pmid 23788689?><pub-id pub-id-type="pmid">23788689</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0248726.ref040">
                <label>40</label>
                <mixed-citation publication-type="journal"><name><surname>Choquet</surname><given-names>H</given-names></name>, <name><surname>Cavalcanti-Proenca</surname><given-names>C</given-names></name>, <name><surname>Lecoeur</surname><given-names>C</given-names></name>, <name><surname>Dina</surname><given-names>C</given-names></name>, <name><surname>Cauchi</surname><given-names>S</given-names></name>, <name><surname>Vaxillaire</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>The T-381C SNP in BNP gene may be modestly associated with type 2 diabetes: an updated meta-analysis in 49 279 subjects</article-title>. <source>Hum Mol Genet</source>. <year>2009</year>;<volume>18</volume>(<issue>13</issue>):<fpage>2495</fpage>–<lpage>501</lpage>. Epub 2009/04/21. <pub-id pub-id-type="doi">10.1093/hmg/ddp169</pub-id> .<?supplied-pmid 19377085?><pub-id pub-id-type="pmid">19377085</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0248726.ref041">
                <label>41</label>
                <mixed-citation publication-type="journal"><name><surname>Meroufel</surname><given-names>DN</given-names></name>, <name><surname>Ouhaibi-Djellouli</surname><given-names>H</given-names></name>, <name><surname>Mediene-Benchekor</surname><given-names>S</given-names></name>, <name><surname>Hermant</surname><given-names>X</given-names></name>, <name><surname>Grenier-Boley</surname><given-names>B</given-names></name>, <name><surname>Lardjam-Hetraf</surname><given-names>SA</given-names></name>, <etal>et al</etal>. <article-title>Examination of the brain natriuretic peptide rs198389 single-nucleotide polymorphism on type 2 diabetes mellitus and related phenotypes in an Algerian population</article-title>. <source>Gene</source>. <year>2015</year>;<volume>567</volume>(<issue>2</issue>):<fpage>159</fpage>–<lpage>63</lpage>. Epub 2015/05/03. <pub-id pub-id-type="doi">10.1016/j.gene.2015.04.073</pub-id> .<?supplied-pmid 25934190?><pub-id pub-id-type="pmid">25934190</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
